{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 57918, "items": [{"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T01:19:19Z", "timestamp": 1525396759621}, "reference-count": 0, "publisher": "Springer Nature", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Pharmacology & Therapeutics"], "published-print": {"date-parts": [[2004, 2]]}, "DOI": "10.1016/j.clpt.2003.11.064", "type": "journal-article", "created": {"date-parts": [[2004, 2, 10]], "date-time": "2004-02-10T10:17:53Z", "timestamp": 1076408273000}, "page": "P17", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Molt-4 rho(0) cells up regulate stress-induced survival genes in an attempt to overcome the potentially lethal consequence of mitochondrial DNA depletion"], "prefix": "10.1038", "volume": "75", "author": [{"given": "A", "family": "Olszanski", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Clinical Pharmacology & Therapeutics"], "language": "en", "deposited": {"date-parts": [[2015, 2, 11]], "date-time": "2015-02-11T15:27:22Z", "timestamp": 1423668442000}, "score": 18.140299, "issued": {"date-parts": [[2004, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 2]]}, "issue": "2"}, "alternative-id": ["S0009-9236(03)00411-9"], "URL": "http://dx.doi.org/10.1016/j.clpt.2003.11.064", "ISSN": ["0009-9236"], "issn-type": [{"value": "0009-9236", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T12:38:14Z", "timestamp": 1525437494279}, "publisher-location": "Berlin, Heidelberg", "reference-count": 0, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642643002", "type": "print"}, {"value": "9783642601965", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1999]]}, "DOI": "10.1007/978-3-642-60196-5_127", "type": "book-chapter", "created": {"date-parts": [[2011, 9, 12]], "date-time": "2011-09-12T23:51:30Z", "timestamp": 1315871490000}, "page": "565-568", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Flow Cytometric Testing of Blood Platelet Activation in Diving"], "prefix": "10.1007", "author": [{"given": "R.", "family": "Olszanski", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Advances in High Pressure Bioscience and Biotechnology"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-60196-5_127", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2014, 1, 25]], "date-time": "2014-01-25T15:37:41Z", "timestamp": 1390664261000}, "score": 18.140299, "issued": {"date-parts": [[1999]]}, "ISBN": ["9783642643002", "9783642601965"], "references-count": 0, "URL": "http://dx.doi.org/10.1007/978-3-642-60196-5_127"}, {"indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T20:21:52Z", "timestamp": 1525724512150}, "reference-count": 0, "publisher": "Wiley", "issue": "6Part13", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1", "start": {"date-parts": [[2013, 6, 1]], "date-time": "2013-06-01T00:00:00Z", "timestamp": 1370044800000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions", "start": {"date-parts": [[2013, 6, 6]], "date-time": "2013-06-06T00:00:00Z", "timestamp": 1370476800000}, "delay-in-days": 5, "content-version": "vor"}], "content-domain": {"domain": ["aip.org"], "crossmark-restriction": true}, "short-container-title": ["Med. Phys."], "published-print": {"date-parts": [[2013, 6]]}, "DOI": "10.1118/1.4814637", "type": "journal-article", "created": {"date-parts": [[2013, 7, 11]], "date-time": "2013-07-11T11:35:59Z", "timestamp": 1373542559000}, "page": "250-250", "update-policy": "http://dx.doi.org/10.1063/aip-crossmark-policy-page", "source": "Crossref", "is-referenced-by-count": 0, "title": ["SU-E-T-202: Statistical Analysis of Patient's Treatment Site Specific QA Using MapCHECK2 for Local Delivery Guideline"], "prefix": "10.1002", "volume": "40", "author": [{"given": "X", "family": "Ding", "sequence": "first", "affiliation": []}, {"given": "A", "family": "Olszanski", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2013, 6, 6]]}, "container-title": ["Medical Physics"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1118%2F1.4814637", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1118/1.4814637/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 5, 18]], "date-time": "2017-05-18T16:56:19Z", "timestamp": 1495126579000}, "score": 16.554228, "issued": {"date-parts": [[2013, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013, 6]]}, "issue": "6Part13"}, "URL": "http://dx.doi.org/10.1118/1.4814637", "archive": ["Portico"], "ISSN": ["0094-2405"], "issn-type": [{"value": "0094-2405", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 11, 14]], "date-time": "2018-11-14T22:40:10Z", "timestamp": 1542235210989}, "reference-count": 0, "publisher": "New England Journal of Medicine (NEJM/MMS)", "issue": "20", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["N Engl J Med"], "published-print": {"date-parts": [[2018, 11, 15]]}, "DOI": "10.1056/nejmicm1805380", "type": "journal-article", "created": {"date-parts": [[2018, 11, 14]], "date-time": "2018-11-14T22:05:06Z", "timestamp": 1542233106000}, "page": "e36", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Melanoma in the Bronchus"], "prefix": "10.1056", "volume": "379", "author": [{"ORCID": "http://orcid.org/0000-0001-8269-7240", "authenticated-orcid": false, "given": "Christopher", "family": "Manley", "sequence": "first", "affiliation": [{"name": "Fox Chase Cancer Center, Philadelphia, PA"}]}, {"given": "Anthony", "family": "Olszanski", "sequence": "additional", "affiliation": [{"name": "Fox Chase Cancer Center, Philadelphia, PA"}]}], "member": "150", "container-title": ["New England Journal of Medicine"], "language": "en", "link": [{"URL": "http://www.nejm.org/doi/pdf/10.1056/NEJMicm1805380", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 14]], "date-time": "2018-11-14T22:05:07Z", "timestamp": 1542233107000}, "score": 16.554228, "issued": {"date-parts": [[2018, 11, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2018, 11, 15]]}, "issue": "20"}, "alternative-id": ["10.1056/NEJMicm1805380"], "URL": "http://dx.doi.org/10.1056/nejmicm1805380", "relation": {"is-supplemented-by": [{"id-type": "doi", "id": "10.1056/NEJMdo005423", "asserted-by": "subject"}]}, "ISSN": ["0028-4793", "1533-4406"], "issn-type": [{"value": "0028-4793", "type": "print"}, {"value": "1533-4406", "type": "electronic"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2018, 5, 9]], "date-time": "2018-05-09T10:55:48Z", "timestamp": 1525863348875}, "reference-count": 0, "publisher": "Harborside Press, LLC", "issue": "5S", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Natl Compr Canc Netw"], "published-print": {"date-parts": [[2015, 5]]}, "DOI": "10.6004/jnccn.2015.0199", "type": "journal-article", "created": {"date-parts": [[2017, 4, 14]], "date-time": "2017-04-14T16:06:56Z", "timestamp": 1492186016000}, "page": "670-672", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Principles of Immunotherapy"], "prefix": "10.6004", "volume": "13", "author": [{"given": "Anthony J.", "family": "Olszanski", "sequence": "first", "affiliation": []}], "member": "4047", "published-online": {"date-parts": [[2015, 5, 20]]}, "container-title": ["Journal of the National Comprehensive Cancer Network"], "language": "en", "deposited": {"date-parts": [[2017, 4, 14]], "date-time": "2017-04-14T16:07:01Z", "timestamp": 1492186021000}, "score": 16.554228, "issued": {"date-parts": [[2015, 5]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2015, 5, 20]]}, "published-print": {"date-parts": [[2015, 5]]}, "issue": "5S"}, "alternative-id": ["10.6004/jnccn.2015.0199"], "URL": "http://dx.doi.org/10.6004/jnccn.2015.0199", "ISSN": ["1540-1405", "1540-1413"], "issn-type": [{"value": "1540-1405", "type": "print"}, {"value": "1540-1413", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 5]], "date-time": "2018-05-05T02:41:57Z", "timestamp": 1525488117154}, "reference-count": 0, "publisher": "SAGE Publications", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["New Labor Forum"], "published-print": {"date-parts": [[2006, 5, 1]]}, "DOI": "10.1080/10957960500446726", "type": "journal-article", "created": {"date-parts": [[2006, 2, 17]], "date-time": "2006-02-17T20:02:33Z", "timestamp": 1140206553000}, "page": "132-133", "source": "Crossref", "is-referenced-by-count": 0, "title": ["LETTERS"], "prefix": "10.1177", "volume": "15", "author": [{"given": "Bruce", "family": "Nissen", "sequence": "first", "affiliation": []}, {"given": "Mike", "family": "Olszanski", "sequence": "additional", "affiliation": []}], "member": "179", "container-title": ["New Labor Forum"], "deposited": {"date-parts": [[2014, 12, 29]], "date-time": "2014-12-29T18:05:28Z", "timestamp": 1419876328000}, "score": 16.554228, "issued": {"date-parts": [[2006, 5, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006, 5, 1]]}, "issue": "1"}, "alternative-id": ["JMP533V053686706"], "URL": "http://dx.doi.org/10.1080/10957960500446726", "ISSN": ["1095-7960"], "issn-type": [{"value": "1095-7960", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 11, 20]], "date-time": "2018-11-20T00:42:35Z", "timestamp": 1542674555496}, "reference-count": 0, "publisher": "Academy of Managed Care Pharmacy", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JMCP"], "published-print": {"date-parts": [[2014, 4]]}, "DOI": "10.18553/jmcp.2014.20.4.346", "type": "journal-article", "created": {"date-parts": [[2016, 2, 16]], "date-time": "2016-02-16T18:22:08Z", "timestamp": 1455646928000}, "page": "346-356", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Current and Future Roles of Targeted Therapy and Immunotherapy in Advanced Melanoma"], "prefix": "10.18553", "volume": "20", "author": [{"given": "Anthony J.", "family": "Olszanski", "sequence": "first", "affiliation": []}], "member": "7818", "container-title": ["Journal of Managed Care Pharmacy"], "language": "en", "deposited": {"date-parts": [[2016, 2, 21]], "date-time": "2016-02-21T14:29:58Z", "timestamp": 1456064998000}, "score": 16.554228, "issued": {"date-parts": [[2014, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 4]]}, "issue": "4"}, "alternative-id": ["10.18553/jmcp.2014.20.4.346"], "URL": "http://dx.doi.org/10.18553/jmcp.2014.20.4.346", "ISSN": ["1083-4087", "1944-706X"], "issn-type": [{"value": "1083-4087", "type": "print"}, {"value": "1944-706X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 9]], "date-time": "2018-05-09T10:55:48Z", "timestamp": 1525863348872}, "reference-count": 0, "publisher": "Harborside Press, LLC", "issue": "suppl 2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Natl Compr Canc Netw"], "published-print": {"date-parts": [[2014, 10]]}, "DOI": "10.6004/jnccn.2014.0216", "type": "journal-article", "created": {"date-parts": [[2017, 4, 14]], "date-time": "2017-04-14T16:05:54Z", "timestamp": 1492185954000}, "page": "S-1-S-5", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Full Spectrum: Efficacy and Toxicity of Immunotherapy in Metastatic Melanoma"], "prefix": "10.6004", "volume": "12", "author": [{"given": "Matthew", "family": "Zibelman", "sequence": "first", "affiliation": []}, {"given": "Anthony J.", "family": "Olszanski", "sequence": "additional", "affiliation": []}], "member": "4047", "published-online": {"date-parts": [[2014, 10, 13]]}, "container-title": ["Journal of the National Comprehensive Cancer Network"], "language": "en", "deposited": {"date-parts": [[2017, 4, 14]], "date-time": "2017-04-14T16:05:55Z", "timestamp": 1492185955000}, "score": 15.408624, "issued": {"date-parts": [[2014, 10]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 10, 13]]}, "published-print": {"date-parts": [[2014, 10]]}, "issue": "suppl 2"}, "alternative-id": ["10.6004/jnccn.2014.0216"], "URL": "http://dx.doi.org/10.6004/jnccn.2014.0216", "ISSN": ["1540-1405", "1540-1413"], "issn-type": [{"value": "1540-1405", "type": "print"}, {"value": "1540-1413", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 5]], "date-time": "2018-05-05T05:15:21Z", "timestamp": 1525497321244}, "reference-count": 0, "publisher": "Dove Medical Press Ltd.", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/3.0/", "start": {"date-parts": [[2012, 3, 1]], "date-time": "2012-03-01T00:00:00Z", "timestamp": 1330560000000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["IJN"], "DOI": "10.2147/ijn.s27994", "type": "journal-article", "created": {"date-parts": [[2012, 3, 15]], "date-time": "2012-03-15T02:26:52Z", "timestamp": 1331778412000}, "page": "1441", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Probable biofilm formation in the cheek as a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16"], "prefix": "10.2147", "author": [{"given": "Tommaso", "family": "Iannitti", "sequence": "first", "affiliation": []}, {"family": "Marusza", "sequence": "additional", "affiliation": []}, {"family": "Mlynarczyk", "sequence": "additional", "affiliation": []}, {"family": "Olszanski", "sequence": "additional", "affiliation": []}, {"given": "B", "family": "Palmieri", "sequence": "additional", "affiliation": []}], "member": "895", "published-online": {"date-parts": [[2012, 3]]}, "container-title": ["International Journal of Nanomedicine"], "language": "en", "link": [{"URL": "https://www.dovepress.com/getfile.php?fileID=12291", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 10, 30]], "date-time": "2016-10-30T22:11:03Z", "timestamp": 1477865463000}, "score": 13.923992, "issued": {"date-parts": [[2012, 3]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2147/ijn.s27994", "ISSN": ["1178-2013"], "issn-type": [{"value": "1178-2013", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T03:07:12Z", "timestamp": 1525748832879}, "reference-count": 10, "publisher": "Springer Nature", "issue": "1", "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["j. immunotherapy cancer"], "published-print": {"date-parts": [[2016, 12]]}, "DOI": "10.1186/s40425-016-0114-4", "type": "journal-article", "created": {"date-parts": [[2016, 2, 8]], "date-time": "2016-02-08T11:34:02Z", "timestamp": 1454931242000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Autoimmune inner ear disease in a melanoma patient treated with pembrolizumab"], "prefix": "10.1186", "volume": "4", "author": [{"given": "Matthew", "family": "Zibelman", "sequence": "first", "affiliation": []}, {"given": "Natasha", "family": "Pollak", "sequence": "additional", "affiliation": []}, {"given": "Anthony J", "family": "Olszanski", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 2, 16]]}, "reference": [{"issue": "3", "key": "114_CR1", "doi-asserted-by": "crossref", "first-page": "914", "DOI": "10.3390/toxins6030914", "volume": "6", "author": "L Gelao", "year": "2014", "unstructured": "Gelao L, Criscitiello C, Esposito A, Goldhirsch A, Curigliano G. Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an \u201cinnocent bystander\u201d. Toxins. 2014;6(3):914\u201333. doi: 10.3390/toxins6030914 .", "journal-title": "Toxins"}, {"issue": "21", "key": "114_CR2", "doi-asserted-by": "crossref", "first-page": "2691", "DOI": "10.1200/JCO.2012.41.6750", "volume": "30", "author": "JS Weber", "year": "2012", "unstructured": "Weber JS, Kahler KC, Hauschild A. Management of immune-related adverse events and kinetics of response with ipilimumab. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(21):2691\u20137. doi: 10.1200/JCO.2012.41.6750 .", "journal-title": "J Clin Oncol Off J Am Soc Clin Oncol"}, {"issue": "1", "key": "114_CR3", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1189/jlb.1212631", "volume": "94", "author": "MK Callahan", "year": "2013", "unstructured": "Callahan MK, Wolchok JD. At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. J Leukoc Biol. 2013;94(1):41\u201353. doi: 10.1189/jlb.1212631 .", "journal-title": "J Leukoc Biol"}, {"issue": "4", "key": "114_CR4", "doi-asserted-by": "crossref", "first-page": "1361", "DOI": "10.1210/jc.2012-4075", "volume": "98", "author": "SM Corsello", "year": "2013", "unstructured": "Corsello SM, Barnabei A, Marchetti P, De Vecchis L, Salvatori R, Torino F. Endocrine side effects induced by immune checkpoint inhibitors. J Clin Endocrinol Metab. 2013;98(4):1361\u201375. doi: 10.1210/jc.2012-4075 .", "journal-title": "J Clin Endocrinol Metab"}, {"key": "114_CR5", "first-page": "206", "volume": "5", "author": "MK Yi-chi", "year": "2014", "unstructured": "Yi-chi MK, Flynn JC. Opportunistic autoimmune disorders potentiated by immune-checkpoint inhibitors anti-CTLA-4 and anti-PD-1. Front Immunol. 2014;5:206. doi: 10.3389/fimmu.2014.00206 .", "journal-title": "Front Immunol"}, {"issue": "3", "key": "114_CR6", "doi-asserted-by": "crossref", "first-page": "535", "DOI": "10.1182/blood-2009-03-211714", "volume": "114", "author": "LA Johnson", "year": "2009", "unstructured": "Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, Hughes MS, et al. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood. 2009;114(3):535\u201346. doi: 10.1182/blood-2009-03-211714 .", "journal-title": "Blood"}, {"issue": "4", "key": "114_CR7", "doi-asserted-by": "crossref", "first-page": "744", "DOI": "10.1177/0194599812448356", "volume": "147", "author": "BJ Seaman", "year": "2012", "unstructured": "Seaman BJ, Guardiani EA, Brewer CC, Zalewski CK, King KA, Rudy S, et al. Audiovestibular dysfunction associated with adoptive cell immunotherapy for melanoma. Otolaryngol Head Neck Surgery Off J Am Acad Otolaryngol Head aNeck Surgery. 2012;147(4):744\u20139. doi: 10.1177/0194599812448356 .", "journal-title": "Otolaryngol Head Neck Surgery Off J Am Acad Otolaryngol Head aNeck Surgery"}, {"issue": "1", "key": "114_CR8", "doi-asserted-by": "crossref", "first-page": "250", "DOI": "10.1111/imr.12134", "volume": "257", "author": "C Yee", "year": "2014", "unstructured": "Yee C. The use of endogenous T cells for adoptive transfer. Immunol Rev. 2014;257(1):250\u201363. doi: 10.1111/imr.12134 .", "journal-title": "Immunol Rev"}, {"issue": "11", "key": "114_CR9", "doi-asserted-by": "crossref", "first-page": "1033", "DOI": "10.1016/j.autrev.2013.01.004", "volume": "12", "author": "A Greco", "year": "2013", "unstructured": "Greco A, Fusconi M, Gallo A, Turchetta R, Marinelli C, Macri GF, et al. Vogt-Koyanagi-Harada syndrome. Autoimmun Rev. 2013;12(11):1033\u20138. doi: 10.1016/j.autrev.2013.01.004 .", "journal-title": "Autoimmun Rev"}, {"key": "114_CR10", "unstructured": "Yamaguchi Y, Hearing VJ. Melanocytes and their diseases. Cold Spring Harbor Perspectives Med 2014;4(5). doi: 10.1101/cshperspect.a017046 .", "DOI": "10.1101/cshperspect.a017046", "doi-asserted-by": "crossref"}], "container-title": ["Journal for ImmunoTherapy of Cancer"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/s40425-016-0114-4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T05:26:26Z", "timestamp": 1498281986000}, "score": 13.923992, "issued": {"date-parts": [[2016, 2, 16]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[2016, 12]]}, "issue": "1"}, "alternative-id": ["114"], "URL": "http://dx.doi.org/10.1186/s40425-016-0114-4", "relation": {"cites": []}, "ISSN": ["2051-1426"], "issn-type": [{"value": "2051-1426", "type": "electronic"}], "article-number": "8"}, {"indexed": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T22:53:28Z", "timestamp": 1525301608740}, "reference-count": 29, "publisher": "Elsevier BV", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1977, 1, 1]], "date-time": "1977-01-01T00:00:00Z", "timestamp": 220924800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Inorganica Chimica Acta"], "published-print": {"date-parts": [[1977, 1]]}, "DOI": "10.1016/s0020-1693(00)94716-9", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T17:47:30Z", "timestamp": 1027619250000}, "page": "L4-L6", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Coordination chemistry of scandium. IX. Scandium (III) complexes with the neutral macrocyclic ligands Me4Bz2[14] tetraeneN4 and Me4[14] tetraeneN4"], "prefix": "10.1016", "volume": "23", "author": [{"given": "Dennis J.", "family": "Olszanski", "sequence": "first", "affiliation": []}, {"given": "Gordon A.", "family": "Melson", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Inorganica Chimica Acta"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0020169300947169?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0020169300947169?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 14]], "date-time": "2017-06-14T23:08:05Z", "timestamp": 1497481685000}, "score": 13.923992, "issued": {"date-parts": [[1977, 1]]}, "references-count": 29, "alternative-id": ["S0020169300947169"], "URL": "http://dx.doi.org/10.1016/s0020-1693(00)94716-9", "ISSN": ["0020-1693"], "issn-type": [{"value": "0020-1693", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T22:45:33Z", "timestamp": 1525301133437}, "reference-count": 36, "publisher": "Elsevier BV", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1978, 1, 1]], "date-time": "1978-01-01T00:00:00Z", "timestamp": 252460800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Inorganica Chimica Acta"], "published-print": {"date-parts": [[1978, 1]]}, "DOI": "10.1016/s0020-1693(00)87225-4", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T17:20:56Z", "timestamp": 1027617656000}, "page": "263-269", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Coordination chemistry of scandium. X. Macrocyclic polyether complexes of scandium(III)"], "prefix": "10.1016", "volume": "26", "author": [{"given": "Dennis J.", "family": "Olszanski", "sequence": "first", "affiliation": []}, {"given": "Gordon A.", "family": "Melson", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Inorganica Chimica Acta"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0020169300872254?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0020169300872254?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 14]], "date-time": "2017-06-14T22:55:11Z", "timestamp": 1497480911000}, "score": 13.923992, "issued": {"date-parts": [[1978, 1]]}, "references-count": 36, "alternative-id": ["S0020169300872254"], "URL": "http://dx.doi.org/10.1016/s0020-1693(00)87225-4", "ISSN": ["0020-1693"], "issn-type": [{"value": "0020-1693", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 1, 3]], "date-time": "2019-01-03T13:43:03Z", "timestamp": 1546522983229}, "reference-count": 0, "publisher": "Harborside Press, LLC", "issue": "5S", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Natl Compr Canc Netw"], "published-print": {"date-parts": [[2013, 5]]}, "DOI": "10.6004/jnccn.2013.0192", "type": "journal-article", "created": {"date-parts": [[2017, 4, 14]], "date-time": "2017-04-14T16:03:23Z", "timestamp": 1492185803000}, "page": "645-648", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Progress in the Management of Melanoma in 2013"], "prefix": "10.6004", "volume": "11", "author": [{"given": "Daniel G.", "family": "Coit", "sequence": "first", "affiliation": []}, {"given": "Anthony J.", "family": "Olszanski", "sequence": "additional", "affiliation": []}], "member": "4047", "published-online": {"date-parts": [[2013, 5, 23]]}, "container-title": ["Journal of the National Comprehensive Cancer Network"], "language": "en", "deposited": {"date-parts": [[2017, 4, 14]], "date-time": "2017-04-14T16:03:36Z", "timestamp": 1492185816000}, "score": 13.923992, "issued": {"date-parts": [[2013, 5]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2013, 5, 23]]}, "published-print": {"date-parts": [[2013, 5]]}, "issue": "5S"}, "alternative-id": ["10.6004/jnccn.2013.0192"], "URL": "http://dx.doi.org/10.6004/jnccn.2013.0192", "ISSN": ["1540-1405", "1540-1413"], "issn-type": [{"value": "1540-1405", "type": "print"}, {"value": "1540-1413", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 10, 19]], "date-time": "2018-10-19T13:14:09Z", "timestamp": 1539954849510}, "reference-count": 19, "publisher": "Emerald", "license": [{"URL": "http://www.emeraldinsight.com/page/tdm", "start": {"date-parts": [[2018, 10, 19]], "date-time": "2018-10-19T00:00:00Z", "timestamp": 1539907200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Aircraft Eng & Aerospace Tech"], "DOI": "10.1108/aeat-02-2018-0092", "type": "journal-article", "created": {"date-parts": [[2018, 10, 19]], "date-time": "2018-10-19T12:56:33Z", "timestamp": 1539953793000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Research and selection of MALE wing profile"], "prefix": "10.1108", "author": [{"given": "Cezary", "family": "Gorniak", "sequence": "first", "affiliation": [{"name": "Department of Aircraft Design, Faculty of Power and Aeronautical Engineering, Warsaw University of Technology, Warszawa, Poland"}]}, {"given": "Zdobyslaw Jan", "family": "Goraj", "sequence": "additional", "affiliation": [{"name": "Division of Aeroplanes and Helicopters, Institute of Aeronautics and Applied Mechanics, Faculty of Power and Aeronautical Engineering, Warsaw University of Technology, Warsaw, Poland"}]}, {"given": "Bartosz", "family": "Olszanski", "sequence": "additional", "affiliation": [{"name": "Department of Aerodynamics, Faculty of Power and Aeronautical Engineering, Warsaw University of Technology, Warszawa, Poland"}]}], "member": "140", "published-online": {"date-parts": [[2018, 10, 19]]}, "reference": [{"key": "ref001", "author": "Barlow J.B.", "year": "1999", "edition": "3", "volume-title": "Low-Speed Tunnel Testing"}, {"key": "ref002", "author": "Drela M.", "volume": "125", "first-page": "1990", "year": "1990", "journal-title": "Applied Computational Aerodynamics, Progress in Astronautics and Aerodynamics"}, {"key": "ref003", "author": "Drela M.", "year": "1990", "volume-title": "AIAA 90-1470, AIAA Fluid Dynamics, Plasmodynamics and Laser Conference"}, {"key": "ref004", "author": "Drela M.", "year": "1994", "volume-title": "A User`s Guide to MSES V2.6"}, {"key": "ref005", "DOI": "10.2514/6.2007-2965", "doi-asserted-by": "publisher"}, {"key": "ref006", "DOI": "10.1108/AEAT-02-2013-0036", "doi-asserted-by": "publisher"}, {"key": "ref007", "unstructured": "Goraj, Z., Nowakowski, M. and Hajduk, J. (2010a), \u201cLong term influence of UAVNET/USICO/CAPECON projects on polish UAS activities (research/design/testing/production/education etc)\u201d, UAVNET WORKSHOP No. 18, Tel Aviv, 20-21 October, available at: www.uavnet.org (accessed 20 November 2011)."}, {"key": "ref008", "author": "Goraj Z.", "year": "2010", "volume-title": "Proceedings of 27th International Congress of the Aeronautical Sciences"}, {"key": "ref009", "author": "Goraj Z.", "year": "2012", "volume-title": "Proceedings of 28th International Congress of the Aeronautical Sciences"}, {"key": "ref010", "unstructured": "Goraj, Z., Frydrychewicz, A., Grendysa, A., Figat, M., Gorniak, C., Hernik, B., Malinowski, M., Goliszek, B., Kowalski, M., Pasternak, F. and Wierzbinska-Prus, B. (2016), \u201cOptimization and in-flight research of a manned MALE class aircraft. Description of project proposal\u201d, POIR.04.01.04-00-0127/15, (unpublished), Warsaw."}, {"key": "ref011", "author": "Gudmundsson S.", "year": "2014", "volume-title": "General Aviation Aircraft Design Applied Methods and Procedures"}, {"key": "ref012", "DOI": "10.1002/9781119406303", "doi-asserted-by": "publisher"}, {"key": "ref013", "DOI": "10.2514/4.861840", "doi-asserted-by": "publisher"}, {"key": "ref014", "DOI": "10.2514/6.1997-514", "doi-asserted-by": "publisher"}, {"key": "ref015", "author": "Marques P.", "year": "2017", "volume-title": "Advanced UAV Aerodynamics, Flight Stability and Control \u2013 Novel Concepts, Theory and Applications"}, {"key": "ref019", "author": "Shepshelovich M.", "year": "2004", "volume-title": "Proceedings of 44th Israel Annual Conference on Aerospace Sciences"}, {"key": "ref017", "DOI": "10.2514/6.2004-1052", "doi-asserted-by": "publisher"}, {"key": "ref018", "DOI": "10.2514/6.2003-603", "doi-asserted-by": "publisher"}, {"key": "ref020", "author": "Liebeck R.H.", "volume": "125", "year": "1990", "journal-title": "Applied Computational Aerodynamics, Progress in Astronautics and Aerodynamics"}], "container-title": ["Aircraft Engineering and Aerospace Technology"], "language": "en", "link": [{"URL": "https://www.emeraldinsight.com/doi/full-xml/10.1108/AEAT-02-2018-0092", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://www.emeraldinsight.com/doi/full/10.1108/AEAT-02-2018-0092", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 10, 19]], "date-time": "2018-10-19T12:56:47Z", "timestamp": 1539953807000}, "score": 13.923992, "issued": {"date-parts": [[2018, 10, 19]]}, "references-count": 19, "alternative-id": ["10.1108/AEAT-02-2018-0092"], "URL": "http://dx.doi.org/10.1108/aeat-02-2018-0092", "relation": {"cites": []}, "ISSN": ["0002-2667"], "issn-type": [{"value": "0002-2667", "type": "print"}], "article-number": "AEAT-02-2018-0092"}, {"indexed": {"date-parts": [[2018, 12, 20]], "date-time": "2018-12-20T17:22:51Z", "timestamp": 1545326571620}, "reference-count": 24, "publisher": "FapUNIFESP (SciELO)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pr\u00f3-Fono R. Atual. Cient."], "published-print": {"date-parts": [[2010, 9]]}, "abstract": "<jats:p>TEMA: \u00e9 comum a queixa de dificuldade de compreens\u00e3o da fala em indiv\u00edduos que apresentam zumbido com ou sem perda auditiva. Para conhecer se o zumbido interfere no processamento auditivo e compreens\u00e3o da fala em sujeitos com audiometria normal, foi realizado este trabalho. OBJETIVO: foi avaliar e comparar o comportamento auditivo de resolu\u00e7\u00e3o temporal e de aten\u00e7\u00e3o seletiva de indiv\u00edduos adultos com audiometria normal, com e sem zumbido. M\u00c9TODO: 45 indiv\u00edduos, 15 com zumbido constante e 30 sem zumbido, foram selecionados e avaliados por meio de tr\u00eas testes de processamento auditivo: Teste de Fala com Ru\u00eddo Branco, Teste Dic\u00f3tico de D\u00edgitos e Gaps In Noise. Em seguida os resultados de cada grupo foram comparados entre si, utilizando testes estat\u00edsticos apropriados, dentre eles o ANOVA. RESULTADOS: n\u00e3o foi observada diferen\u00e7a estatisticamente significante entre os grupos em ambas as orelhas. CONCLUS\u00c3O: o zumbido n\u00e3o interferiu nas habilidades auditivas de aten\u00e7\u00e3o seletiva e resolu\u00e7\u00e3o temporal.</jats:p>", "DOI": "10.1590/s0104-56872010000300013", "type": "journal-article", "created": {"date-parts": [[2010, 11, 19]], "date-time": "2010-11-19T19:48:27Z", "timestamp": 1290196107000}, "page": "233-238", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Resolu\u00e7\u00e3o temporal e aten\u00e7\u00e3o seletiva de indiv\u00edduos com zumbido"], "prefix": "10.1590", "volume": "22", "author": [{"given": "Isabela Olszanski", "family": "Acrani", "sequence": "first", "affiliation": [{"name": "Universidade Federal de S\u00e3o Paulo"}]}, {"given": "Liliane Desgualdo", "family": "Pereira", "sequence": "additional", "affiliation": [{"name": "Unifesp"}]}], "member": "530", "reference": [{"key": "ref1", "author": "Eggermont JJ.", "first-page": "S7", "year": "2003", "article-title": "Central Tinnitus", "journal-title": "Auris Nasus Larynx.", "DOI": "10.1016/S0385-8146(02)00122-0", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "ref2", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1016/S0030-6665(02)00160-3", "article-title": "Classification and epidemiology of tinnitus", "volume": "36", "author": "Heller AJ.", "year": "2003", "journal-title": "Otolaryngol Clin N Am."}, {"key": "ref3", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1093/bmb/63.1.195", "article-title": "Mechanisms of tinnitus", "volume": "63", "author": "Baguley DM.", "year": "2000", "journal-title": "British Medical Bulletin."}, {"key": "ref4", "first-page": "236", "article-title": "Neurophysiological Approach to Tinnitus Patients", "volume": "17", "author": "Jastreboff PJ", "year": "1996", "journal-title": "Am J. Otol."}, {"issue": "1-2", "key": "ref5", "doi-asserted-by": "crossref", "DOI": "10.1016/j.heares.2006.09.003", "article-title": "High-frequency tinnitus without hearing loss does not mean absence of deafferentation", "volume": "222", "author": "Weisz N", "year": "2006", "journal-title": "Hear Res."}, {"issue": "3", "key": "ref6", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1016/j.mehy.2006.01.061", "article-title": "Is tinnitus useful in early detection of incoming heart decompensation?", "volume": "67", "author": "Borghi C", "year": "2006", "journal-title": "Med Hypotheses."}, {"issue": "2", "key": "ref7", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1016/j.mehy.2006.12.068", "article-title": "Could echocardiography yield a cardiovascular profile of the tinnitus prone subject?", "volume": "70", "author": "Pirodda A", "year": "2008", "journal-title": "Med Hypotheses."}, {"issue": "5", "key": "ref8", "doi-asserted-by": "crossref", "first-page": "208", "DOI": "10.1080/14992020601102329", "article-title": "Severe tinnitus and its effect on selective and divided attention", "volume": "46", "author": "Stevens C", "year": "2007", "journal-title": "Int J Audiol."}, {"issue": "4", "key": "ref9", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1007/s10484-008-9065-y", "article-title": "Alterations in Event Related Potentials (ERP) Associated with Tinnitus Distress and Attention", "volume": "33", "author": "Delb W", "year": "2008", "journal-title": "Appl Psychophysiol Biofeedback."}, {"issue": "1-2", "key": "ref10", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1016/S0378-5955(03)00172-2", "article-title": "Habituation deficit in auditory event-related potencials in tinnitus complainers", "volume": "181", "author": "Walpurger V", "year": "2003", "journal-title": "Hear Res."}, {"issue": "1", "key": "ref11", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.3109/00206099409072954", "article-title": "Relationships among psychoacoustic judgments, speech understanding ability and self-perceived handicap in tinnitus subjects", "volume": "33", "author": "Newman CW", "year": "1994", "journal-title": "Audiology."}, {"key": "ref12", "author": "Branco-Barreiro FCA.", "series-title": "Zumbido em adultos ouvintes normais: um estudo sobre o processamento auditivo central e o handicap"}, {"issue": "1", "key": "ref13", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1159/000096713", "article-title": "Relationships among Speech Perception, Self-Rated Tinnitus Loudness and Disability in Tinnitus Patients with Normal Pure-Tone Thresholds of Hearing", "volume": "69", "author": "Huang CY", "year": "2007", "journal-title": "ORL."}, {"issue": "3", "key": "ref14", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1590/S0104-56872005000300004", "article-title": "Tinnitus Handicap Inventory: adapta\u00e7\u00e3o cultural para o Portugu\u00eas Brasileiro", "volume": "17", "author": "Ferreira PEA", "year": "2005", "journal-title": "Pr\u00f3-fono"}, {"issue": "2", "key": "ref15", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1001/archotol.1996.01890140029007", "article-title": "The development of the Tinnitus Handicap Inventory", "volume": "122", "author": "Newman CW", "year": "1996", "journal-title": "Arch. Otolaryngol. Head Neck Surg."}, {"issue": "5", "key": "ref16", "doi-asserted-by": "crossref", "first-page": "388", "DOI": "10.1046/j.1365-2273.2001.00490.x", "article-title": "Guidelines for the grading of tinnitus severity: the results of a working group commissioned by the British Association of Otolaryngologists, Head and Neck Surgeons", "volume": "26", "author": "McCombe A", "year": "2001", "journal-title": "Clin Otolaryngol", "ISSN": "http://id.crossref.org/issn/0307-7772", "issn-type": "print"}, {"key": "ref17", "series-title": "Tratado de Fonoaudiologia", "first-page": "111", "volume-title": "Avalia\u00e7\u00e3o do processamento auditivo central", "author": "Pereira LD.", "year": "2005", "edition": "2"}, {"key": "ref18", "author": "Pereira LD.", "series-title": "Processamento auditivo central: uma revis\u00e3o cr\u00edtica"}, {"issue": "1", "key": "ref19", "doi-asserted-by": "crossref", "first-page": "166", "DOI": "10.1016/j.brainres.2005.11.023", "article-title": "Temporal resolution properties of human auditory cortex: reflections in the neuromagnetic auditory evoked M100 component", "volume": "1069", "author": "Gage N", "year": "2006", "journal-title": "Brain Res."}, {"issue": "6", "key": "ref20", "doi-asserted-by": "crossref", "first-page": "608", "DOI": "10.1097/01.aud.0000188069.80699.41", "article-title": "GIN (Gaps-In-Noise) Test Performance in Subjects with Confirmed Central Auditory Nervous System Involvement", "volume": "26", "author": "Musiek FE", "year": "2005", "journal-title": "Ear Hear."}, {"issue": "5", "key": "ref21", "doi-asserted-by": "crossref", "first-page": "238", "DOI": "10.1080/14992020801908244", "article-title": "The gaps-in-noise test: Gap detection thresholds in normal-hearing young adults", "volume": "47", "author": "Samelli AG", "year": "2008", "journal-title": "Int J Audiol."}, {"issue": "7", "key": "ref22", "first-page": "22", "article-title": "Investiga\u00e7\u00e3o audiol\u00f3gica em ouvintes com zumbido", "volume": "5", "author": "Branco-Barreiro FCA", "year": "2000", "journal-title": "Rev. Soc. Bras. Fonoaudiol."}, {"key": "ref23", "author": "Perez A.", "series-title": "Estudo dos limiares de detec\u00e7\u00e3o de GAP, com o uso do teste GIN, em crian\u00e7as de 11 e 12 anos"}, {"key": "ref24", "author": "Sanches SGG.", "series-title": "Fun\u00e7\u00e3o coclear e resolu\u00e7\u00e3o temporal em indiv\u00edduos com zumbido"}], "container-title": ["Pr\u00f3-Fono Revista de Atualiza\u00e7\u00e3o Cient\u00edfica"], "link": [{"URL": "http://www.scielo.br/pdf/pfono/v22n3/a13v22n3.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 5, 26]], "date-time": "2017-05-26T17:58:45Z", "timestamp": 1495821525000}, "score": 13.923992, "issued": {"date-parts": [[2010, 9]]}, "references-count": 24, "journal-issue": {"published-print": {"date-parts": [[2010, 9]]}, "issue": "3"}, "alternative-id": ["S0104-56872010000300013"], "URL": "http://dx.doi.org/10.1590/s0104-56872010000300013", "relation": {"cites": []}, "ISSN": ["0104-5687"], "issn-type": [{"value": "0104-5687", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 8, 5]], "date-time": "2018-08-05T22:12:02Z", "timestamp": 1533507122313}, "publisher-location": "Weinheim, Germany", "reference-count": 153, "publisher": "Wiley-VCH Verlag GmbH & Co. KGaA", "isbn-type": [{"value": "9783527329373", "type": "print"}, {"value": "9783527682423", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9783527682423.ch27", "type": "book-chapter", "created": {"date-parts": [[2014, 8, 12]], "date-time": "2014-08-12T13:41:04Z", "timestamp": 1407850864000}, "page": "787-822", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Antibodies in Cancer Treatment: Early Clinical Development"], "prefix": "10.1002", "author": [{"given": "Matthew", "family": "Zibelman", "sequence": "first", "affiliation": []}, {"given": "Hossein", "family": "Borghaei", "sequence": "additional", "affiliation": []}, {"given": "Anthony J.", "family": "Olszanski", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2014, 8, 12]]}, "reference": [{"key": "10.1002/9783527682423.ch27-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "495", "DOI": "10.1038/256495a0", "article-title": "Continuous cultures of fused cells secreting antibody of predefined specificity", "volume": "256", "author": "Kohler", "year": "1975", "journal-title": "Nature"}, {"key": "10.1002/9783527682423.ch27-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "1822", "DOI": "10.3324/haematol.2011.047159", "article-title": "The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden", "volume": "96", "author": "Boross", "year": "2011", "journal-title": "Haematologica"}, {"key": "10.1002/9783527682423.ch27-BIB3|cit3", "first-page": "676", "article-title": "Mechanisms of action of CD20 antibodies", "volume": "2", "author": "Boross", "year": "2012", "journal-title": "Am. J. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "458", "DOI": "10.1016/j.jbspin.2009.03.010", "article-title": "Monoclonal anti-CD20 antibodies: mechanisms of action and monitoring of biological effects", "volume": "76", "author": "Renaudineau", "year": "2009", "journal-title": "Joint Bone Spine: Rev. Rhum."}, {"key": "10.1002/9783527682423.ch27-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "5322", "DOI": "10.1182/blood-2009-01-200469", "article-title": "Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model", "volume": "114", "author": "Wang", "year": "2009", "journal-title": "Blood"}, {"key": "10.1002/9783527682423.ch27-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "3940", "DOI": "10.1200/JCO.2003.05.013", "article-title": "Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma", "volume": "21", "author": "Weng", "year": "2003", "journal-title": "J. Clin. Oncol."}, {"issue": "5", "key": "10.1002/9783527682423.ch27-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "3657", "DOI": "10.1167/iovs.12-10316", "article-title": "Preclinical study of A Glycoengineered anti-human CD20 antibody in murine models of primary cerebral and intraocular B-Cell lymphomas", "volume": "54", "author": "Abdelwahed", "year": "2013", "journal-title": "Invest. Ophthalmol. Visual Sci."}, {"key": "10.1002/9783527682423.ch27-BIB8|cit8", "author": "Le Garff-Tavernier", "year": "2012", "volume-title": "Ublituximab, an Optimized Anti-CD20 Monoclonal Antibody, Demonstrates Greater NK-Mediated ADCC Than Rituximab in Waldenstrom's Macroglobulinemia Patients Supporting a Therapeutic Strategy with Ublituximab"}, {"key": "10.1002/9783527682423.ch27-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "558", "DOI": "10.1136/gut.48.4.558", "article-title": "Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders", "volume": "48", "author": "Zhu", "year": "2001", "journal-title": "Gut"}, {"key": "10.1002/9783527682423.ch27-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "1403", "DOI": "10.1111/j.1349-7006.2009.01206.x", "article-title": "Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma", "volume": "100", "author": "Shirakawa", "year": "2009", "journal-title": "Cancer Sci."}, {"key": "10.1002/9783527682423.ch27-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "9832", "DOI": "10.1158/0008-5472.CAN-08-1973", "article-title": "Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer", "volume": "68", "author": "Ishiguro", "year": "2008", "journal-title": "Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "920", "DOI": "10.1158/1078-0432.CCR-12-2616", "article-title": "First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma", "volume": "19", "author": "Zhu", "year": "2013", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB13|cit13", "author": "Luka", "volume": "2011", "year": "2010", "article-title": "Development of a serum biomarker assay that differentiates tumor-associated MUC5AC (NPC-1C ANTIGEN) from normal MUC5AC", "journal-title": "BioMed. Res. Int."}, {"key": "10.1002/9783527682423.ch27-BIB14|cit14", "first-page": "235", "article-title": "NPC-1C: a novel, therapeutic antibody to treat pancreas and colorectal cancers", "volume": "29", "author": "Diaz", "year": "2011", "journal-title": "J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB15|cit15", "unstructured": "Morse , M Diaz , L Azad , N 2012 A phase I/IIA safety study of NPC-1C: a novel therapeutic antibody to treat pancreas and colorectal cancers. American Society of Clinical Oncology Gastrointestinal Cancer Symposium, San Francisco, CA"}, {"key": "10.1002/9783527682423.ch27-BIB16|cit16", "first-page": "2346", "article-title": "Chemotherapy-refractory diffuse large B-cell lymphomas (DLBCL) are effectively killed by ofatumumab-induced complement-mediated cytoxicity", "volume": "110", "author": "Cillessen", "year": "2007", "journal-title": "Blood (New York)"}, {"key": "10.1002/9783527682423.ch27-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "747", "DOI": "10.3109/10428191003672123", "article-title": "Veltuzumab (humanized anti-CD20 monoclonal antibody): characterization, current clinical results, and future prospects", "volume": "51", "author": "Goldenberg", "year": "2010", "journal-title": "Leuk. Iymphoma"}, {"key": "10.1002/9783527682423.ch27-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "3346", "DOI": "10.1200/JCO.2008.19.9117", "article-title": "Humanized anti-CD20 antibody, veltuzumab, in refractory/recurrent non-Hodgkin's lymphoma: phase I/II results", "volume": "27", "author": "Morschhauser", "year": "2009", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB19|cit19", "first-page": "3254", "article-title": "Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors", "volume": "60", "author": "Scott", "year": "2000", "journal-title": "Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "3286", "DOI": "10.1158/1078-0432.CCR-07-0284", "article-title": "A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen", "volume": "13", "author": "Scott", "year": "2007", "journal-title": "Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB21|cit21", "first-page": "7086", "article-title": "Targeting Lewis Y (LeY) in small cell lung cancer (SCLC) with a humanzied monoclonal antibody, hu3S193", "volume": "24", "author": "Krug", "year": "2006", "journal-title": "J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB22|cit22", "author": "Smaletz", "year": "2011", "volume-title": "Anti-LeY Monoclonal Antibody hu3S193 in Patients with Avanced Platinum Resistant/Refractory Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer"}, {"key": "10.1002/9783527682423.ch27-BIB23|cit23", "first-page": "3856", "article-title": "Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing epitopes consisting of sialyl or sialyl-fucosyl type 1 chain", "volume": "48", "author": "Kannagi", "year": "1988", "journal-title": "Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB24|cit24", "first-page": "e15118", "article-title": "Effect of AbGn-7, a glycotope-specific monoclonal antibody, on apoptosis in colon cancer cells and tumor growth in xenograft models", "volume": "27", "author": "Lin", "year": "2009", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1016/S1470-2045(02)00650-2", "article-title": "The biological treatment of renal-cell carcinoma and melanoma", "volume": "3", "author": "Nathan", "year": "2002", "journal-title": "Lancet Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "440", "DOI": "10.1053/j.seminoncol.2010.09.004", "article-title": "Ipilimumab: unleashing the power of the immune system through CTLA-4 blockade", "volume": "37", "author": "Boasberg", "year": "2010", "journal-title": "Semin. Oncol.: Elsevier"}, {"key": "10.1002/9783527682423.ch27-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1056/NEJMoa1003466", "article-title": "Improved survival with ipilimumab in patients with metastatic melanoma", "volume": "363", "author": "Hodi", "year": "2010", "journal-title": "N. Engl. J. Med."}, {"issue": "6", "key": "10.1002/9783527682423.ch27-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "1021", "DOI": "10.1007/s00262-013-1418-6", "article-title": "Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme", "volume": "62", "author": "Di Giacomo", "year": "2013", "journal-title": "Cancer Immunol., Immunother.: CII"}, {"key": "10.1002/9783527682423.ch27-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "2691", "DOI": "10.1200/JCO.2012.41.6750", "article-title": "Management of immune-related adverse events and kinetics of response with ipilimumab", "volume": "30", "author": "Weber", "year": "2012", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "616", "DOI": "10.1200/JCO.2012.44.6112", "article-title": "Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma", "volume": "31", "author": "Ribas", "year": "2013", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9", "article-title": "PD-1: PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2", "volume": "32", "author": "Carter", "year": "2002", "journal-title": "Eur. J. Immunol."}, {"key": "10.1002/9783527682423.ch27-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "12293", "DOI": "10.1073/pnas.192461099", "article-title": "Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade", "volume": "99", "author": "Iwai", "year": "2002", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "10.1002/9783527682423.ch27-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1593/neo.05733", "article-title": "The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors", "volume": "8", "author": "Ghebeh", "year": "2006", "journal-title": "Neoplasia (New York)"}, {"key": "10.1002/9783527682423.ch27-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "3381", "DOI": "10.1158/0008-5472.CAN-05-4303", "article-title": "Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up", "volume": "66", "author": "Thompson", "year": "2006", "journal-title": "Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1016/j.acthis.2006.01.003", "article-title": "Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance", "volume": "108", "author": "Wu", "year": "2006", "journal-title": "Acta Histochem."}, {"key": "10.1002/9783527682423.ch27-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "3167", "DOI": "10.1200/JCO.2009.26.7609", "article-title": "Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates", "volume": "28", "author": "Brahmer", "year": "2010", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "3044", "DOI": "10.1158/1078-0432.CCR-07-4079", "article-title": "Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies", "volume": "14", "author": "Berger", "year": "2008", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "2443", "DOI": "10.1056/NEJMoa1200690", "article-title": "Safety, activity, and immune correlates of anti-PD-1 antibody in cancer", "volume": "366", "author": "Topalian", "year": "2012", "journal-title": "N. Engl. J. Med."}, {"key": "10.1002/9783527682423.ch27-BIB39|cit39", "unstructured": "Stockwell , S. 2013 ONLINE FIRST: immunotherapy poised to \u2018change treatment paradigm\u2019in melanoma, other solid tumors"}, {"key": "10.1002/9783527682423.ch27-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "2455", "DOI": "10.1056/NEJMoa1200694", "article-title": "Safety and activity of anti-PD-L1 antibody in patients with advanced cancer", "volume": "366", "author": "Brahmer", "year": "2012", "journal-title": "N. Engl. J. Med."}, {"key": "10.1002/9783527682423.ch27-BIB41|cit41", "author": "Gordon", "year": "2013", "volume-title": "A Phase 1 Study of MPDL3280A, an Engineered PD-L1 Antibody with Locally Advanced or Metastatic Tumors"}, {"key": "10.1002/9783527682423.ch27-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "2176", "DOI": "10.2174/138920111798808392", "article-title": "Antibody targeting of TGF-in cancer patients", "volume": "12", "author": "Lonning", "year": "2011", "journal-title": "Curr. Pharm. Biotechnol."}, {"key": "10.1002/9783527682423.ch27-BIB43|cit43", "first-page": "9028", "article-title": "Phase I/II Study of GC1008: a human anti-transforming growth factor-beta (TGF-\u03b2) monoclonal antibody (MAb) in patients with advanced malignant melanoma (MM) or renal cell carcinoma (RCC)", "volume": "26", "author": "Morris", "year": "2008", "journal-title": "J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB44|cit44", "author": "Mukherjee", "year": "2011", "volume-title": "The Emperor of All Maladies: A Biography of Cancer"}, {"key": "10.1002/9783527682423.ch27-BIB45|cit45", "unstructured": "Hadari , Y.R. Doody , J.F. Wang , Y.F. Patel , S.N. Apblett , R.L. et\u00a0al 2004 The IgG1 monoclonal antibody cetuximab induces degradation of the epidermal growth factor receptor. ASCO Gastrointestinal Cancers Symposium 22 24"}, {"key": "10.1002/9783527682423.ch27-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1111/j.1365-2249.2009.03992.x", "article-title": "Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy", "volume": "158", "author": "Martinelli", "year": "2009", "journal-title": "Clin. Exp. Immunol."}, {"key": "10.1002/9783527682423.ch27-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1158/1541-7786.MCR-07-0072", "article-title": "Angiopoietin: a TIE (d) balance in tumor angiogenesis", "volume": "5", "author": "Shim", "year": "2007", "journal-title": "Mol. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB48|cit48", "first-page": "1321", "article-title": "MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models", "volume": "40", "author": "Leow", "year": "2012", "journal-title": "Int. J. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.1016/S0959-8049(12)71835-X", "article-title": "36 improved inhibition of tumor growth by the novel monoclonal antibody VGX-100 targeting VEGF-C in combination with VEGF-receptor tyrosine kinase inhibitors", "volume": "48", "author": "Tester", "year": "2012", "journal-title": "Eur. J. Cancer"}, {"key": "10.1002/9783527682423.ch27-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "1314", "DOI": "10.1158/0008-5472.CAN-08-2791", "article-title": "Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy", "volume": "69", "author": "Indraccolo", "year": "2009", "journal-title": "Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1186/2045-824X-3-18", "article-title": "Anti-DLL4, a cancer therapeutic with multiple mechanisms of action", "volume": "3", "author": "Gurney", "year": "2011", "journal-title": "Vasc Cell"}, {"key": "10.1002/9783527682423.ch27-BIB52|cit52", "unstructured": "Smith , D. Eisenberg , P. Stagg , R. Manikhas , G. Pavlovskiy , A. et\u00a0al 2010 A First-In-human, phase I trial of the anti-DLL4 antibody (OMP-21M18) targeting cancer stem cells in patients with advanced solid tumors. 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics"}, {"key": "10.1002/9783527682423.ch27-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1016/S0959-8049(12)72395-X", "article-title": "598 a phase 1b study of demcizumab plus pemetrexed and carboplatin in patients with 1st line Non-Small Cell Lung Cancer (NSCLC)", "volume": "48", "author": "McKeage", "year": "2012", "journal-title": "Eur. J. Cancer"}, {"key": "10.1002/9783527682423.ch27-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1023/A:1023768811842", "article-title": "c-Met: structure, functions and potential for therapeutic inhibition", "volume": "22", "author": "Ma", "year": "2003", "journal-title": "Cancer Metastasis. Rev."}, {"key": "10.1002/9783527682423.ch27-BIB55|cit55", "unstructured": "Meetze , A.K. Connoly , K. Boudrow , A. Venkataraman , S. Medicherla , S. et\u00a0al 2009 Preclinical efficacy and pharmacodynamics of SCH 900105 (AV-299) and anti-HGF antibody in an intracranial glioblastoma. AACR-NCI-EORTC International Conference Molecular Target and Cancer Therapeutics"}, {"key": "10.1002/9783527682423.ch27-BIB56|cit56", "author": "Meetze", "volume": "8", "year": "2009", "article-title": "Anti-tumor activity of SCH 900105 (AV299), an anti-HGF antibody in non-small cell lung cancer models", "journal-title": "Mol. Cancer Ther.", "DOI": "10.1158/1535-7163.TARG-09-C173", "doi-asserted-by": "crossref"}, {"key": "10.1002/9783527682423.ch27-BIB57|cit57", "author": "Yu", "volume": "29", "year": "2011", "article-title": "Exploratory biomarker analyses from OAM4558g: a placebo-controlled phase II study of erlotinib with or without MetMAb in patients with advanced non-small cell lung cancer (NSCLC)", "journal-title": "J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB58|cit58", "unstructured": "Genentech Media Relations. Genentech Provides Update on Phase III study of Onartuzumab in People with Specific Type of Lung Cancer www.gene.com/media/press-releases/14562/2014-03-02/genentech-provides-update-on-phase-iii-s"}, {"key": "10.1002/9783527682423.ch27-BIB59|cit59", "doi-asserted-by": "crossref", "first-page": "717", "DOI": "10.1016/j.ejca.2006.01.003", "article-title": "Tumour-associated macrophages are a distinct M2 polarized population promoting tumour progression: potential targets of anti-cancer therapy", "volume": "42", "author": "Sica", "year": "2006", "journal-title": "Eur. J. Cancer"}, {"key": "10.1002/9783527682423.ch27-BIB60|cit60", "doi-asserted-by": "crossref", "first-page": "727", "DOI": "10.1084/jem.193.6.727", "article-title": "Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy", "volume": "193", "author": "Lin", "year": "2001", "journal-title": "J. Exp. Med."}, {"key": "10.1002/9783527682423.ch27-BIB61|cit61", "doi-asserted-by": "crossref", "first-page": "1223", "DOI": "10.1007/s12272-011-0821-9", "article-title": "Tanibirumab (TTAC-0001): A fully human monoclonal antibody targets vascular endothelial growth factor receptor 2 (VEGFR-2)", "volume": "34", "author": "Lee", "year": "2011", "journal-title": "Arch. Pharmacal Res."}, {"key": "10.1002/9783527682423.ch27-BIB62|cit62", "doi-asserted-by": "crossref", "first-page": "1027", "DOI": "10.1002/cncr.24789", "article-title": "Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1", "volume": "116", "author": "Schwartz", "year": "2010", "journal-title": "Cancer"}, {"key": "10.1002/9783527682423.ch27-BIB63|cit63", "author": "Krishnamurthi", "volume": "26", "year": "2008", "article-title": "Phase 1 study of weekly anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody IMC-18F1 in patients with advanced solid malignancies", "journal-title": "J. Clin. Oncol. ASCO"}, {"key": "10.1002/9783527682423.ch27-BIB64|cit64", "doi-asserted-by": "crossref", "first-page": "5549s", "DOI": "10.1158/1078-0432.CCR-07-1109", "article-title": "IMC-A12, a human IgG1 monoclonal antibody to the insulin-like growth factor I receptor", "volume": "13", "author": "Rowinsky", "year": "2007", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB65|cit65", "first-page": "7500", "article-title": "Randomized, open label, phase III trial of figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC)", "volume": "28", "author": "Jassem", "year": "2010", "journal-title": "J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB66|cit66", "doi-asserted-by": "crossref", "first-page": "2625", "DOI": "10.1158/1078-0432.CCR-12-0061", "article-title": "Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumors", "volume": "18", "author": "Naing", "year": "2012", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB67|cit67", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1097/JTO.0b013e31823c5b11", "article-title": "A phase I/II study of erlotinib in combination with the anti-insulin-like growth factor-1 receptor monoclonal antibody IMC-A12 (cixutumumab) in patients with advanced non-small cell lung cancer", "volume": "7", "author": "Weickhardt", "year": "2012", "journal-title": "J. Thorac. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB68|cit68", "doi-asserted-by": "crossref", "first-page": "6304", "DOI": "10.1158/1078-0432.CCR-10-3336", "article-title": "A phase I pharmacokinetic and pharmacodynamic study of dalotuzumab (MK-0646), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in patients with advanced solid tumors", "volume": "17", "author": "Atzori", "year": "2011", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB69|cit69", "first-page": "3008", "article-title": "A phase I study of the oral mTOR inhibitor ridaforolimus (RIDA) in combination with the IGF-1R antibody dalotozumab (DALO) in patients (pts) with advanced solid tumors", "volume": "28", "author": "Di Cosimo", "year": "2010", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB70|cit70", "first-page": "4039", "article-title": "Phase I/II study of MK-0646, the humanized monoclonal IGF-1R antibody in combination with gemcitabine or gemcitabine plus erlotinib (E) for advanced pancreatic cancer", "volume": "28", "author": "Javle", "year": "2010", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB71|cit71", "first-page": "4163", "article-title": "A phase II clinical trial of MK-0646, an insulin-like growth factor-1 receptor inhibitor (IGF-1R), in patients with metastatic well-differentiated neuroendocrine tumors (NETs)", "volume": "28", "author": "Reidy", "year": "2010", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB72|cit72", "first-page": "4127", "article-title": "A phase II study of the anti-IGFR antibody MK-0646 in combination with cetuximab and irinotecan in the treatment of chemorefractory metastatic colorectal cancer", "volume": "27", "author": "Watkins", "year": "2009", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB73|cit73", "doi-asserted-by": "crossref", "first-page": "977", "DOI": "10.1093/annonc/mdl475", "article-title": "Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer", "volume": "18", "author": "Valabrega", "year": "2007", "journal-title": "Ann. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB74|cit74", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1093/annonc/mds328", "article-title": "Pertuzumab: new hope for patients with HER2-positive breast cancer", "volume": "24", "author": "Capelan", "year": "2013", "journal-title": "Ann. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB75|cit75", "doi-asserted-by": "crossref", "first-page": "2733", "DOI": "10.1158/1538-7445.AM2012-2733", "article-title": "LJM716: an anti-HER3 antibody that inhibits both HER2 and NRG driven tumor growth by trapping HER3 in the inactive conformation", "volume": "72", "author": "Garner", "year": "2012", "journal-title": "Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB76|cit76", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1016/S1359-6349(08)72243-2", "article-title": "309 POSTER Fully human anti-HER3 mAb U3-1287 (AMG 888) demonstrates unique in vitro and in vivo activities versus other HER family inhibitors in NSCLC models", "volume": "6", "author": "Treder", "year": "2008", "journal-title": "Eur. J. Cancer Suppl."}, {"issue": "11", "key": "10.1002/9783527682423.ch27-BIB77|cit77", "doi-asserted-by": "crossref", "first-page": "3078", "DOI": "10.1158/1078-0432.CCR-12-3051", "article-title": "Phase I study of U3-1287, a fully human anti-HER3 monoclonal antibody, in patients with advanced solid tumors", "volume": "19", "author": "LoRusso", "year": "2013", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB78|cit78", "first-page": "2609", "article-title": "Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins", "volume": "118", "author": "Guix", "year": "2008", "journal-title": "J. Clin. Invest."}, {"key": "10.1002/9783527682423.ch27-BIB79|cit79", "doi-asserted-by": "crossref", "first-page": "PR6", "DOI": "10.1158/1078-0432.12AACRIASLC-PR6", "article-title": "Abstract PR6: phase 1b/2 trial of HER3 inhibitor U3-1287 in combination with erlotinib in advanced NSCLC patients (pts): HERALD study", "volume": "18", "author": "von Pawel", "year": "2012", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB80|cit80", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1023/A:1023956223037", "article-title": "Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth", "volume": "79", "author": "Liby", "year": "2003", "journal-title": "Breast Cancer Res. Treat."}, {"key": "10.1002/9783527682423.ch27-BIB81|cit81", "doi-asserted-by": "crossref", "first-page": "863", "DOI": "10.1016/S0002-9440(10)65333-3", "article-title": "Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions", "volume": "154", "author": "Leav", "year": "1999", "journal-title": "Am. J. Pathol."}, {"key": "10.1002/9783527682423.ch27-BIB82|cit82", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1158/1535-7163.MCT-12-0886", "article-title": "Neutralization of prolactin receptor function by monoclonal antibody LFA102, a novel potential therapeutic for the treatment of breast cancer", "volume": "12", "author": "Damiano", "year": "2013", "journal-title": "Mol. Cancer Ther."}, {"key": "10.1002/9783527682423.ch27-BIB83|cit83", "doi-asserted-by": "crossref", "first-page": "6606", "DOI": "10.1158/1078-0432.CCR-04-0182", "article-title": "CD74 is expressed by multiple myeloma and is a promising target for therapy", "volume": "10", "author": "Burton", "year": "2004", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB84|cit84", "doi-asserted-by": "crossref", "first-page": "4807", "DOI": "10.1182/blood-2005-11-4334", "article-title": "Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival", "volume": "107", "author": "Starlets", "year": "2006", "journal-title": "Blood"}, {"key": "10.1002/9783527682423.ch27-BIB85|cit85", "doi-asserted-by": "crossref", "first-page": "2554", "DOI": "10.1182/blood-2009-11-253203", "article-title": "Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells", "volume": "116", "author": "Hertlein", "year": "2010", "journal-title": "Blood"}, {"key": "10.1002/9783527682423.ch27-BIB86|cit86", "first-page": "8593", "article-title": "Dose-escalation trial of milatuzumab (humanized anti-CD74 monoclonal antibody) in multiple myeloma", "volume": "27", "author": "Kaufman", "year": "2009", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB87|cit87", "doi-asserted-by": "crossref", "first-page": "S255", "DOI": "10.1016/j.clml.2011.09.172", "article-title": "5.18 milatuzumab as a single agent in refractory chronic lymphocytic leukemia: interim results of a phase 1-2 study and future plans", "volume": "11", "author": "Haran", "year": "2011", "journal-title": "Clin. Lymphoma Myeloma Leukemia"}, {"key": "10.1002/9783527682423.ch27-BIB88|cit88", "doi-asserted-by": "crossref", "first-page": "420", "DOI": "10.1038/nrc821", "article-title": "Targeting death and decoy receptors of the tumour-necrosis factor superfamily", "volume": "2", "author": "Ashkenazi", "year": "2002", "journal-title": "Nat. Rev. Cancer"}, {"key": "10.1002/9783527682423.ch27-BIB89|cit89", "doi-asserted-by": "crossref", "first-page": "1060", "DOI": "10.1093/annonc/mdn015", "article-title": "A novel humanized anti-human death receptor 5 antibody CS-1008 induces apoptosis in tumor cells without toxicity in hepatocytes", "volume": "19", "author": "Yada", "year": "2008", "journal-title": "Ann. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB90|cit90", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1089/cbr.2009.0673", "article-title": "Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5)", "volume": "25", "author": "Forero-Torres", "year": "2010", "journal-title": "Cancer Biother. Radiopharm."}, {"key": "10.1002/9783527682423.ch27-BIB91|cit91", "author": "Ciprotti", "year": "2013", "volume-title": "A Phase I Imaging and Pharmocodynamic Trial of CS-1008 in Patients with Metastatic Colorectal Cancer"}, {"key": "10.1002/9783527682423.ch27-BIB92|cit92", "first-page": "1490", "article-title": "Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia", "volume": "7", "author": "Bross", "year": "2001", "journal-title": "Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB93|cit93", "first-page": "790a", "article-title": "Preliminary results of Southwest Oncology Group Study S0106: an international intergroup phase 3 randomized trial comparing the addition of gemtuzumab ozogamicin to standard induction therapy versus standard induction therapy followed by a second randomization to post-consolidation gemtuzumab ozogamicin versus no additional therapy for previously untreated acute myeloid leukemia", "volume": "114", "author": "Petersdorf", "year": "2009", "journal-title": "Blood"}, {"key": "10.1002/9783527682423.ch27-BIB94|cit94", "doi-asserted-by": "crossref", "first-page": "3921", "DOI": "10.1200/JCO.2012.43.0132", "article-title": "Gemtuzumab ozogamicin: time to resurrect?", "volume": "30", "author": "Ravandi", "year": "2012", "journal-title": "J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB95|cit95", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.2165/11530960-000000000-00000", "article-title": "Bispecific antibodies for cancer immunotherapy: current perspectives", "volume": "24", "author": "M\u00fcller", "year": "2010", "journal-title": "BioDrugs"}, {"key": "10.1002/9783527682423.ch27-BIB96|cit96", "author": "Geretti", "volume": "10", "year": "2011", "article-title": "HER2-targeted liposomal doxorubicin MM-302 has a favorable cardio safety profile in preclinical models", "journal-title": "Mol. Cancer Ther.", "DOI": "10.1158/1535-7163.TARG-11-C90", "doi-asserted-by": "crossref"}, {"key": "10.1002/9783527682423.ch27-BIB97|cit97", "author": "Munster", "year": "2012", "volume-title": "A Phase I Study of MM-302, a HER2- Targeted Liposomal Doxorubicin, in Patients with Advanced, HER2-Positive Breast Cancer"}, {"key": "10.1002/9783527682423.ch27-BIB98|cit98", "first-page": "3071", "article-title": "The effect of SGN-75, a novel antibody--drug conjugate (ADC), in treatment of patients with renal cell carcinoma (RCC) or non-Hodgkin lymphoma (NHL): a phase I study", "volume": "29", "author": "Thompson", "year": "2011", "journal-title": "J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB99|cit99", "doi-asserted-by": "crossref", "first-page": "676", "DOI": "10.1038/sj.bjc.6605816", "article-title": "Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody-drug conjugate SGN-75", "volume": "103", "author": "Ryan", "year": "2010", "journal-title": "Br. J. Cancer"}, {"key": "10.1002/9783527682423.ch27-BIB100|cit100", "doi-asserted-by": "crossref", "first-page": "3937", "DOI": "10.1158/1078-0432.CCR-03-0801", "article-title": "Mesothelin a new target for immunotherapy", "volume": "10", "author": "Hassan", "year": "2004", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB101|cit101", "unstructured": "Bendell , J. Blumenschein , G. Zinner , R. Hong , D. Jones S. 2013 First-in-Human Phase 1 Dose Escalation Study of a Novel Anti-Mesothelin Antibody Drug Conjugate, BAY 94-9343, in Patients with Advanced Solid Tumors, American Association of Cancer Research, Washington, DC."}, {"key": "10.1002/9783527682423.ch27-BIB102|cit102", "first-page": "8013", "article-title": "Phase I study of lorvotuzumab mertansine (LM, IMGN901) in combination with lenalidomide (Len) and dexamethasone (Dex) in patients with CD56-positive relapsed or relapsed/refractory multiple myeloma (MM)", "volume": "29", "author": "Berdeja", "year": "2011", "journal-title": "J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB103|cit103", "first-page": "536", "article-title": "Phase I study of lorvotuzumab mertansine (IMGN901) in patients with CD56-positive solid tumors", "volume": "21", "author": "Woll", "year": "2010", "journal-title": "Ann. Oncol."}, {"issue": "6", "key": "10.1002/9783527682423.ch27-BIB104|cit104", "doi-asserted-by": "crossref", "first-page": "968", "DOI": "10.1158/1535-7163.MCT-12-1170", "article-title": "Milatuzumab-SN-38 conjugates for the treatment of CD74+ cancers", "volume": "12", "author": "Govindan", "year": "2013", "journal-title": "Mol. Cancer Ther."}, {"key": "10.1002/9783527682423.ch27-BIB105|cit105", "unstructured": "Yardley , D. 2012 A Randomized Phase II Study of the Antibody-drug Conjugate CDX-011 in Advanced GPNMB Overexpressing Breast Cancer: The EMERGE Study"}, {"key": "10.1002/9783527682423.ch27-BIB106|cit106", "author": "Hamid", "volume": "28", "year": "2010", "article-title": "Frequent dosing and GPNMB expression with CDX-011 (CR011-vcMMAE), an antibody-drug conjugate (ADC), in patients with advanced melanoma", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB107|cit107", "author": "Illidge", "year": "1995", "volume-title": "Radioimmunotherapy"}, {"key": "10.1002/9783527682423.ch27-BIB108|cit108", "first-page": "2000", "article-title": "Radioimmunotherapy of non-Hodgkin's Lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?", "volume": "44", "author": "Sharkey", "year": "2003", "journal-title": "J. Nucl. Med."}, {"key": "10.1002/9783527682423.ch27-BIB109|cit109", "doi-asserted-by": "crossref", "first-page": "3051", "DOI": "10.1200/JCO.2003.01.082", "article-title": "Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma", "volume": "21", "author": "Leonard", "year": "2003", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB110|cit110", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1038/sj.bmt.1704201", "article-title": "Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias", "volume": "32", "author": "Burke", "year": "2003", "journal-title": "Bone Marrow Transplant."}, {"key": "10.1002/9783527682423.ch27-BIB111|cit111", "doi-asserted-by": "crossref", "first-page": "5303", "DOI": "10.1158/1078-0432.CCR-10-0382", "article-title": "Sequential cytarabine and \u03b1-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia", "volume": "16", "author": "Rosenblat", "year": "2010", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB112|cit112", "first-page": "1233", "article-title": "Targeted \u03b1 particle immunotherapy for myeloid leukemia", "volume": "100", "author": "Jurcic", "year": "2002", "journal-title": "Blood"}, {"key": "10.1002/9783527682423.ch27-BIB113|cit113", "doi-asserted-by": "crossref", "first-page": "558", "DOI": "10.1016/S0952-7915(99)00015-1", "article-title": "Bispecific antibodies in cancer therapy", "volume": "11", "author": "Segal", "year": "1999", "journal-title": "Curr. Opin. Immunol."}, {"key": "10.1002/9783527682423.ch27-BIB114|cit114", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1016/S0167-5699(00)01659-5", "article-title": "Immunotherapeutic perspective for bispecific antibodies", "volume": "21", "author": "van Spriel", "year": "2000", "journal-title": "Immunol. Today"}, {"key": "10.1002/9783527682423.ch27-BIB115|cit115", "doi-asserted-by": "crossref", "first-page": "4941", "DOI": "10.1158/0008-5472.CAN-09-0547", "article-title": "Bispecific T-cell engaging antibodies for cancer therapy", "volume": "69", "author": "Baeuerle", "year": "2009", "journal-title": "Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB116|cit116", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1038/nature05474", "article-title": "Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3", "volume": "445", "author": "Sergina", "year": "2007", "journal-title": "Nature"}, {"key": "10.1002/9783527682423.ch27-BIB117|cit117", "doi-asserted-by": "crossref", "first-page": "1204", "DOI": "10.1158/0008-5472.CAN-09-3321", "article-title": "Heterotrimerization of the growth factor receptors erbB2, erbB3, and insulin-like growth factor-i receptor in breast cancer cells resistant to herceptin", "volume": "70", "author": "Huang", "year": "2010", "journal-title": "Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB118|cit118", "doi-asserted-by": "crossref", "first-page": "582", "DOI": "10.1158/1535-7163.MCT-11-0820", "article-title": "Antitumor activity of a novel bispecific antibody that targets the ErbB2/ErbB3 oncogenic unit and inhibits heregulin-induced activation of ErbB3", "volume": "11", "author": "McDonagh", "year": "2012", "journal-title": "Mol. Cancer Ther."}, {"issue": "15", "key": "10.1002/9783527682423.ch27-BIB119|cit119", "first-page": "TPS169", "article-title": "A phase I/II and pharmacologic study of MM-111 in patients with advanced, refractory HER2-positive (HER2+) cancers", "volume": "28", "author": "Denlinger", "year": "2010", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB120|cit120", "doi-asserted-by": "crossref", "first-page": "824", "DOI": "10.1158/0008-5472.CAN-12-1611", "article-title": "Dual targeting of EGFR and HER3 with MEHD7945A overcomes acquired resistance to EGFR inhibitors and radiation", "volume": "73", "author": "Huang", "year": "2013", "journal-title": "Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB121|cit121", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1358/dof.2008.033.02.1172578", "article-title": "BiTE: a new class of antibodies that recruit T-cells", "volume": "33", "author": "Baeuerle", "year": "2008", "journal-title": "Drugs Future"}, {"key": "10.1002/9783527682423.ch27-BIB122|cit122", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1016/j.leukres.2008.08.025", "article-title": "Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells", "volume": "33", "author": "d'Argouges", "year": "2009", "journal-title": "Leuk. Res."}, {"key": "10.1002/9783527682423.ch27-BIB123|cit123", "doi-asserted-by": "crossref", "first-page": "2493", "DOI": "10.1200/JCO.2010.32.7270", "article-title": "Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival", "volume": "29", "author": "Topp", "year": "2011", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB124|cit124", "doi-asserted-by": "crossref", "first-page": "974", "DOI": "10.1126/science.1158545", "article-title": "Tumor regression in cancer patients by very low doses of a T cell-engaging antibody", "volume": "321", "author": "Bargou", "year": "2008", "journal-title": "Science"}, {"key": "10.1002/9783527682423.ch27-BIB125|cit125", "doi-asserted-by": "crossref", "first-page": "1253", "DOI": "10.1056/NEJMra061808", "article-title": "Cancer stem cells", "volume": "355", "author": "Jordan", "year": "2006", "journal-title": "N. Engl. J. Med."}, {"key": "10.1002/9783527682423.ch27-BIB126|cit126", "first-page": "4105", "article-title": "The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy", "volume": "61", "author": "McLaughlin", "year": "2001", "journal-title": "Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB127|cit127", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1158/1078-0432.CCR-11-1270", "article-title": "EpCAM/CD3-bispecific T-cell engaging antibody MT110 eliminates primary human pancreatic cancer stem cells", "volume": "18", "author": "Cioffi", "year": "2012", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB128|cit128", "first-page": "2618", "article-title": "The role of tumor markers in the management of colorectal cancer", "volume": "50", "author": "Go", "year": "1982", "journal-title": "Cancer"}, {"key": "10.1002/9783527682423.ch27-BIB129|cit129", "doi-asserted-by": "crossref", "first-page": "7981", "DOI": "10.1158/1078-0432.CCR-08-0324", "article-title": "High shed antigen levels within tumors: an additional barrier to immunoconjugate therapy", "volume": "14", "author": "Zhang", "year": "2008", "journal-title": "Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB130|cit130", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1038/sj.bjc.6605364", "article-title": "Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody", "volume": "102", "author": "Osada", "year": "2009", "journal-title": "Br. J. Cancer"}, {"key": "10.1002/9783527682423.ch27-BIB131|cit131", "doi-asserted-by": "crossref", "first-page": "3812", "DOI": "10.1158/1078-0432.CCR-11-3308", "article-title": "Development of a human monoclonal antibody for potential therapy of CD27-expressing lymphoma and leukemia", "volume": "18", "author": "Vitale", "year": "2012", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB132|cit132", "first-page": "3430", "article-title": "Expression and release of CD27 in human B-cell malignancies", "volume": "82", "author": "Van Oers", "year": "1993", "journal-title": "Blood"}, {"key": "10.1002/9783527682423.ch27-BIB133|cit133", "doi-asserted-by": "crossref", "first-page": "829", "DOI": "10.1016/j.bbrc.2010.02.092", "article-title": "Anti-tumor effects of depleting and non-depleting anti-CD27 monoclonal antibodies in immune-competent mice", "volume": "393", "author": "Sakanishi", "year": "2010", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10.1002/9783527682423.ch27-BIB134|cit134", "doi-asserted-by": "crossref", "first-page": "1299", "DOI": "10.1002/jcb.22679", "article-title": "Roles of GRP78 in physiology and cancer", "volume": "110", "author": "Zhang", "year": "2010", "journal-title": "J. Cell. Biochem."}, {"key": "10.1002/9783527682423.ch27-BIB135|cit135", "doi-asserted-by": "crossref", "first-page": "17965", "DOI": "10.1073/pnas.0705647104", "article-title": "Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration", "volume": "104", "author": "Tomkowicz", "year": "2007", "journal-title": "Proc. Natl. Acad. Sci. U.S.A"}, {"key": "10.1002/9783527682423.ch27-BIB136|cit136", "doi-asserted-by": "crossref", "first-page": "4410", "DOI": "10.1158/1538-7445.AM2012-4410", "article-title": "Abstract 4410: Neutralizing Endosialin antibody, MORAb-004, enhances efficacy of TAXOTERE in a metastatic melanoma model", "volume": "72", "author": "Krauthauser", "year": "2012", "journal-title": "Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB137|cit137", "unstructured": "Diaz , L. Azad , N. Gounder , M. Coughlin , C. Fishel J. 2012 A first-in-human phase I study of MORAB-004, a humanized monoclonal antibody recognizing endosialin (TEM-1), in patients with solid tumors. 2012 ASCO Annual Meeting, Chicago, IL"}, {"key": "10.1002/9783527682423.ch27-BIB138|cit138", "author": "Zu Heringdorf", "first-page": "239", "year": "2013", "volume-title": "Sphingolipids: Basic Science and Drug Development"}, {"key": "10.1002/9783527682423.ch27-BIB139|cit139", "first-page": "2560", "article-title": "A phase I study of sonepcizumab (S), a humanized monoclonal antibody to sphingosine-1-phosphate (S1P), in patients with advanced solid tumors", "volume": "28", "author": "Gordon", "year": "2010", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB140|cit140", "author": "Tan", "year": "2011", "article-title": "Abstract A210: mechanism of action of MM-151, a potent mixture of three human antibody antagonists targeting EGFR", "journal-title": "Mol. Cancer Ther.", "DOI": "10.1158/1535-7163.TARG-11-A210", "doi-asserted-by": "crossref"}, {"key": "10.1002/9783527682423.ch27-BIB141|cit141", "author": "Werner", "year": "2011", "article-title": "Abstract A144: Therapeutically targeting high-affinity ligand activation of EGFR with MM-151, an oligoclonal therapeutic", "journal-title": "Mol. Cancer Ther.", "DOI": "10.1158/1535-7163.TARG-11-A144", "doi-asserted-by": "crossref"}, {"key": "10.1002/9783527682423.ch27-BIB142|cit142", "doi-asserted-by": "crossref", "first-page": "1099", "DOI": "10.1200/JCO.2009.25.0597", "article-title": "Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer", "volume": "28", "author": "Kantoff", "year": "2010", "journal-title": "J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB143|cit143", "doi-asserted-by": "crossref", "first-page": "788", "DOI": "10.2741/1837", "article-title": "Costimulatory molecules as adjuvants for immunotherapy", "volume": "11", "author": "Hodge", "year": "2006", "journal-title": "Front. Biosci."}, {"key": "10.1002/9783527682423.ch27-BIB144|cit144", "doi-asserted-by": "crossref", "first-page": "94", "DOI": "10.1111/j.1442-2042.2010.02664.x", "article-title": "Immunological therapy in urological malignancy: novel combination strategies", "volume": "18", "author": "Finley", "year": "2011", "journal-title": "Int. J. Urol."}, {"key": "10.1002/9783527682423.ch27-BIB145|cit145", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1111/j.1440-1711.2006.01446.x", "article-title": "Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1", "volume": "84", "author": "Nicholaou", "year": "2006", "journal-title": "Immunol. Cell Biol."}, {"key": "10.1002/9783527682423.ch27-BIB146|cit146", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.2147/ITT.S35570", "article-title": "Cancer testis antigen and immunotherapy", "volume": "2013", "author": "Krishnadas", "year": "2013", "journal-title": "ImmunoTargets Ther."}, {"key": "10.1002/9783527682423.ch27-BIB147|cit147", "doi-asserted-by": "crossref", "first-page": "1479", "DOI": "10.1016/S0360-3016(02)03928-7", "article-title": "Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy", "volume": "54", "author": "Ran", "year": "2002", "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."}, {"key": "10.1002/9783527682423.ch27-BIB148|cit148", "doi-asserted-by": "crossref", "first-page": "6871", "DOI": "10.1158/1078-0432.CCR-09-1499", "article-title": "Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma", "volume": "15", "author": "He", "year": "2009", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB149|cit149", "doi-asserted-by": "crossref", "first-page": "4408", "DOI": "10.1158/0008-5472.CAN-05-0031", "article-title": "A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice", "volume": "65", "author": "Huang", "year": "2005", "journal-title": "Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB150|cit150", "doi-asserted-by": "crossref", "first-page": "6888", "DOI": "10.1158/1078-0432.CCR-11-1074", "article-title": "Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors", "volume": "17", "author": "Gerber", "year": "2011", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527682423.ch27-BIB151|cit151", "first-page": "7589", "article-title": "Phase II study of bavituximab plus paclitaxel and carboplatin in untreated locally advanced or metastatic non-small cell lung cancer: interim results", "volume": "28", "author": "Digumarti", "year": "2010", "journal-title": "J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB152|cit152", "first-page": "1062", "article-title": "Phase II study of bavituximab plus paclitaxel and carboplatin in locally advanced or metastatic breast cancer: interim results", "volume": "28", "author": "Jain", "year": "2010", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527682423.ch27-BIB153|cit153", "first-page": "3005", "article-title": "Phase II study of bavituximab plus docetaxel in patients with locally advanced or metastatic breast cancer", "volume": "27", "author": "Tabagari", "year": "2009", "journal-title": "J. Clin. Oncol."}], "container-title": ["Handbook of Therapeutic Antibodies"], "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/9783527682423.ch27", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 5]], "date-time": "2018-08-05T21:55:38Z", "timestamp": 1533506138000}, "score": 13.923992, "issued": {"date-parts": [[2014, 8, 12]]}, "ISBN": ["9783527682423", "9783527329373"], "references-count": 153, "URL": "http://dx.doi.org/10.1002/9783527682423.ch27", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2018, 8, 6]], "date-time": "2018-08-06T13:40:44Z", "timestamp": 1533562844707}, "reference-count": 1, "publisher": "Wiley", "issue": "31", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 13909, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Chemischer Informationsdienst"], "published-print": {"date-parts": [[1977, 8, 2]]}, "DOI": "10.1002/chin.197731239", "type": "journal-article", "created": {"date-parts": [[2016, 4, 3]], "date-time": "2016-04-03T12:37:55Z", "timestamp": 1459687075000}, "page": "no-no", "source": "Crossref", "is-referenced-by-count": 0, "title": ["ChemInform Abstract: COORDINATION CHEMISTRY OF SCANDIUM. IX. SCANDIUM(III) COMPLEXES WITH THE NEUTRAL MACROCYCLIC LIGANDS ME4BZ2(14)TETRAENEN4 AND ME4(14)TETRAENEN4"], "prefix": "10.1002", "volume": "8", "author": [{"given": "D. J.", "family": "OLSZANSKI", "sequence": "first", "affiliation": []}, {"given": "G. A.", "family": "MELSON", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2016, 3, 31]]}, "reference": [{"key": "10.1002/chin.197731239-BIB1|cit1", "author": "OLSZANSKI", "volume": "23", "year": "1977", "article-title": "COORDINATION CHEMISTRY OF SCANDIUM. IX. SCANDIUM(III) COMPLEXES WITH THE NEUTRAL MACROCYCLIC LIGANDS ME4BZ2(14)TETRAENEN4 AND ME4(14)TETRAENEN4", "journal-title": "Inorg. Chim. Acta", "DOI": "10.1016/S0020-1693(00)94716-9", "doi-asserted-by": "crossref"}], "container-title": ["Chemischer Informationsdienst"], "language": "en", "link": [{"URL": "http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.197731239", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.197731239", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/chin.197731239", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 6]], "date-time": "2018-08-06T13:13:27Z", "timestamp": 1533561207000}, "score": 13.923992, "issued": {"date-parts": [[1977, 8, 2]]}, "references-count": 1, "journal-issue": {"published-print": {"date-parts": [[1977, 8, 2]]}, "issue": "31"}, "URL": "http://dx.doi.org/10.1002/chin.197731239", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0009-2975"], "issn-type": [{"value": "0009-2975", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 8, 6]], "date-time": "2018-08-06T14:41:20Z", "timestamp": 1533566480965}, "reference-count": 1, "publisher": "Wiley", "issue": "22", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 13608, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Chemischer Informationsdienst"], "published-print": {"date-parts": [[1978, 5, 30]]}, "DOI": "10.1002/chin.197822252", "type": "journal-article", "created": {"date-parts": [[2016, 4, 10]], "date-time": "2016-04-10T18:18:17Z", "timestamp": 1460312297000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["ChemInform Abstract: COORDINATION CHEMISTRY OF SCANDIUM. X. MACROCYCLIC POLYETHER COMPLEXES OF SCANDIUM(III)"], "prefix": "10.1002", "volume": "9", "author": [{"given": "D. J.", "family": "OLSZANSKI", "sequence": "first", "affiliation": []}, {"given": "G. A.", "family": "MELSON", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2016, 4, 5]]}, "reference": [{"key": "10.1002/chin.197822252-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/S0020-1693(00)87225-4", "article-title": "COORDINATION CHEMISTRY OF SCANDIUM. X. MACROCYCLIC POLYETHER COMPLEXES OF SCANDIUM(III)", "volume": "26", "author": "OLSZANSKI", "year": "1978", "journal-title": "Inorg. Chim. Acta"}], "container-title": ["Chemischer Informationsdienst"], "language": "de", "link": [{"URL": "http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.197822252", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.197822252", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/chin.197822252", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 6]], "date-time": "2018-08-06T14:07:27Z", "timestamp": 1533564447000}, "score": 13.923992, "issued": {"date-parts": [[1978, 5, 30]]}, "references-count": 1, "journal-issue": {"published-print": {"date-parts": [[1978, 5, 30]]}, "issue": "22"}, "URL": "http://dx.doi.org/10.1002/chin.197822252", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0009-2975"], "issn-type": [{"value": "0009-2975", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 9, 2]], "date-time": "2018-09-02T15:20:02Z", "timestamp": 1535901602563}, "reference-count": 1, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1", "start": {"date-parts": [[1993, 3, 1]], "date-time": "1993-03-01T00:00:00Z", "timestamp": 730944000000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions", "start": {"date-parts": [[2007, 1, 16]], "date-time": "2007-01-16T00:00:00Z", "timestamp": 1168905600000}, "delay-in-days": 5069, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mediation Quarterly"], "published-print": {"date-parts": [[1993, 3]]}, "DOI": "10.1002/crq.3900100308", "type": "journal-article", "created": {"date-parts": [[2007, 7, 18]], "date-time": "2007-07-18T13:54:29Z", "timestamp": 1184766869000}, "page": "291-302", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Do peaceful conflict management methods pose problems in posttotalitarian Poland?"], "prefix": "10.1002", "volume": "10", "author": [{"given": "Justyna", "family": "Olszanska", "sequence": "first", "affiliation": []}, {"given": "Robert", "family": "Olszanski", "sequence": "additional", "affiliation": []}, {"given": "Jacek", "family": "Wozniak", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2007, 1, 16]]}, "reference": [{"key": "10.1002/crq.3900100308-BIB1|cit1", "author": "Moore", "year": "1986", "volume-title": "The Mediation Process: Practical Strategies for Resolving Conflict"}], "container-title": ["Mediation Quarterly"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcrq.3900100308", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcrq.3900100308", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/crq.3900100308", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 5]], "date-time": "2018-08-05T04:00:45Z", "timestamp": 1533441645000}, "score": 13.923992, "issued": {"date-parts": [[1993, 3]]}, "references-count": 1, "journal-issue": {"published-print": {"date-parts": [[1993, 3]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1002/crq.3900100308", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0739-4098"], "issn-type": [{"value": "0739-4098", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 12, 25]], "date-time": "2018-12-25T22:10:11Z", "timestamp": 1545775811949}, "reference-count": 17, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2000, 4, 1]], "date-time": "2000-04-01T00:00:00Z", "timestamp": 954547200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Lung Cancer"], "published-print": {"date-parts": [[2000, 4]]}, "DOI": "10.3816/clc.2000.s.003", "type": "journal-article", "created": {"date-parts": [[2008, 9, 12]], "date-time": "2008-09-12T01:04:21Z", "timestamp": 1221181461000}, "page": "S15-S19", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Docetaxel and Gemcitabine: A Nonplatinum Combination for Non\u2013Small-Cell Lung Cancer"], "prefix": "10.3816", "volume": "1", "author": [{"given": "Anthony J.", "family": "Olszanski", "sequence": "first", "affiliation": []}, {"given": "James R.", "family": "Rigas", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinical Lung Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S152573041170609X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S152573041170609X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 25]], "date-time": "2018-12-25T21:56:56Z", "timestamp": 1545775016000}, "score": 13.923992, "issued": {"date-parts": [[2000, 4]]}, "references-count": 17, "alternative-id": ["S152573041170609X"], "URL": "http://dx.doi.org/10.3816/clc.2000.s.003", "ISSN": ["1525-7304"], "issn-type": [{"value": "1525-7304", "type": "print"}], "subject": ["Cancer Research", "Oncology", "Pulmonary and Respiratory Medicine"]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T06:07:00Z", "timestamp": 1525327620888}, "reference-count": 0, "publisher": "Cambridge University Press (CUP)", "issue": "05", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Laryngol. Otol."], "published-print": {"date-parts": [[2007, 5]]}, "DOI": "10.1017/s0022215106003793", "type": "journal-article", "created": {"date-parts": [[2006, 10, 25]], "date-time": "2006-10-25T08:21:47Z", "timestamp": 1161764507000}, "source": "Crossref", "is-referenced-by-count": 10, "title": ["Differentiation between cholesteatoma and inflammatory process of the middle ear, based on contrast-enhanced computed tomography imaging"], "prefix": "10.1017", "volume": "121", "author": [{"given": "A", "family": "Trojanowska", "sequence": "first", "affiliation": []}, {"given": "P", "family": "Trojanowski", "sequence": "additional", "affiliation": []}, {"given": "W", "family": "Olszanski", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Klatka", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Drop", "sequence": "additional", "affiliation": []}], "member": "56", "published-online": {"date-parts": [[2006, 10, 19]]}, "container-title": ["The Journal of Laryngology & Otology"], "language": "en", "link": [{"URL": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0022215106003793", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 4, 23]], "date-time": "2017-04-23T13:12:45Z", "timestamp": 1492953165000}, "score": 12.005574, "issued": {"date-parts": [[2006, 10, 19]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2007, 5]]}, "issue": "05"}, "alternative-id": ["S0022215106003793"], "URL": "http://dx.doi.org/10.1017/s0022215106003793", "ISSN": ["0022-2151", "1748-5460"], "issn-type": [{"value": "0022-2151", "type": "print"}, {"value": "1748-5460", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 5]], "date-time": "2018-05-05T21:30:01Z", "timestamp": 1525555801524}, "reference-count": 20, "publisher": "Hindawi Limited", "license": [{"URL": "http://creativecommons.org/licenses/by/3.0/", "start": {"date-parts": [[2012, 1, 1]], "date-time": "2012-01-01T00:00:00Z", "timestamp": 1325376000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Case Reports in Transplantation"], "published-print": {"date-parts": [[2012]]}, "abstract": "<jats:p>Donor transmission of melanoma is one of the more common and lethal of recipient malignancies, often presenting with systemic disease. Although some patients may receive durable remission of melanoma following explantation of the allograft and withdrawal of immunosuppression, donor transmission of melanoma is fatal in most patients. Here we present a case of a 44-year-old male who developed metastatic melanoma following renal transplant.</jats:p>", "DOI": "10.1155/2012/764019", "type": "journal-article", "created": {"date-parts": [[2012, 11, 4]], "date-time": "2012-11-04T21:01:11Z", "timestamp": 1352062871000}, "page": "1-3", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Donor Transmission of Melanoma Following Renal Transplant"], "prefix": "10.1155", "volume": "2012", "author": [{"given": "Kathryn T.", "family": "Chen", "sequence": "first", "affiliation": [{"name": "Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19147, USA"}]}, {"given": "Anthony", "family": "Olszanski", "sequence": "additional", "affiliation": [{"name": "Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19147, USA"}]}, {"ORCID": "http://orcid.org/0000-0003-2966-9704", "authenticated-orcid": true, "given": "Jeffrey M.", "family": "Farma", "sequence": "additional", "affiliation": [{"name": "Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19147, USA"}]}], "member": "98", "reference": [{"key": "1", "DOI": "10.1111/j.1600-6143.2004.00335.x", "doi-asserted-by": "publisher"}, {"key": "2", "DOI": "10.1111/j.1432-2277.2010.01090.x", "doi-asserted-by": "publisher"}, {"key": "3", "volume": "70", "issue": "1", "first-page": "232", "year": "2000", "journal-title": "Transplantation"}, {"key": "4", "DOI": "10.1097/CMR.0b013e32831bc44a", "doi-asserted-by": "publisher"}, {"key": "5", "volume": "74", "issue": "3", "first-page": "358", "year": "2002", "journal-title": "Transplantation", "DOI": "10.1097/00007890-200208150-00011", "doi-asserted-by": "crossref"}, {"key": "6", "volume": "9", "issue": "1", "first-page": "53", "year": "2004", "journal-title": "Annals of Transplantation"}, {"key": "7", "DOI": "10.1016/S1470-2045(10)70024-3", "doi-asserted-by": "publisher"}, {"key": "8", "DOI": "10.1056/NEJM200302063480620", "doi-asserted-by": "publisher"}, {"key": "9", "DOI": "10.1503/cmaj.051428", "doi-asserted-by": "publisher"}, {"key": "10", "volume": "21", "issue": "2", "first-page": "127", "year": "2008", "journal-title": "Proceedings (Baylor University. Medical Center)"}, {"key": "11", "volume": "101", "issue": "29", "first-page": "10501", "year": "2004", "journal-title": "Proceedings of the National Academy of Sciences United States of America", "DOI": "10.1073/pnas.0404036101", "doi-asserted-by": "crossref"}, {"key": "12", "DOI": "10.1158/1078-0432.CCR-06-0823", "doi-asserted-by": "publisher"}, {"key": "13", "DOI": "10.1111/j.1399-0012.2006.00514.x", "doi-asserted-by": "publisher"}, {"key": "14", "volume": "30", "issue": "5", "first-page": "328", "year": "1980", "journal-title": "Transplantation", "DOI": "10.1097/00007890-198011000-00003", "doi-asserted-by": "crossref"}, {"key": "15", "volume": "1", "issue": "8231", "first-page": "1196", "year": "1981", "journal-title": "The Lancet"}, {"key": "16", "DOI": "10.1111/j.1365-2133.2005.07094.x", "doi-asserted-by": "publisher"}, {"key": "17", "DOI": "10.1016/S0190-9622(99)70185-4", "doi-asserted-by": "publisher"}, {"key": "18", "DOI": "10.1097/00007890-199809150-00020", "doi-asserted-by": "publisher"}, {"key": "19", "DOI": "10.1097/00007890-199601270-00019", "doi-asserted-by": "publisher"}, {"key": "20", "volume": "17", "issue": "22", "first-page": "6958", "year": "2011", "journal-title": "Clinical Cancer Research", "DOI": "10.1158/1078-0432.CCR-11-1595", "doi-asserted-by": "crossref"}], "container-title": ["Case Reports in Transplantation"], "language": "en", "link": [{"URL": "http://downloads.hindawi.com/journals/crit/2012/764019.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/crit/2012/764019.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/crit/2012/764019.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 21]], "date-time": "2017-06-21T02:16:40Z", "timestamp": 1498011400000}, "score": 12.005574, "issued": {"date-parts": [[2012]]}, "references-count": 20, "alternative-id": ["764019", "764019"], "URL": "http://dx.doi.org/10.1155/2012/764019", "relation": {"cites": []}, "ISSN": ["2090-6943", "2090-6951"], "issn-type": [{"value": "2090-6943", "type": "print"}, {"value": "2090-6951", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T12:16:31Z", "timestamp": 1525781791814}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "4 Supplement", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Res"], "published-print": {"date-parts": [[2016, 2, 15]]}, "DOI": "10.1158/1538-7445.sabcs15-ot1-01-04", "type": "journal-article", "created": {"date-parts": [[2016, 5, 20]], "date-time": "2016-05-20T08:47:55Z", "timestamp": 1463734075000}, "page": "OT1-01-04-OT1-01-04", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract OT1-01-04: A multicenter, phase 1b, first-in-human dose-escalation study of ADXS31-164, aListeria monocytogenes-LLO immunotherapy, in patients with HER2-expressing solid tumors"], "prefix": "10.1158", "volume": "76", "author": [{"given": "AR", "family": "Tan", "sequence": "first", "affiliation": []}, {"given": "A", "family": "Olszanski", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Golan", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "Mauro", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Rugo", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2016, 2, 18]]}, "container-title": ["Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.SABCS15-OT1-01-04", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T13:31:58Z", "timestamp": 1482499918000}, "score": 12.005574, "issued": {"date-parts": [[2016, 2, 15]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 2, 18]]}, "published-print": {"date-parts": [[2016, 2, 15]]}, "issue": "4 Supplement"}, "alternative-id": ["10.1158/1538-7445.SABCS15-OT1-01-04"], "URL": "http://dx.doi.org/10.1158/1538-7445.sabcs15-ot1-01-04", "ISSN": ["0008-5472", "1538-7445"], "issn-type": [{"value": "0008-5472", "type": "print"}, {"value": "1538-7445", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 4, 13]], "date-time": "2018-04-13T20:57:25Z", "timestamp": 1523653045940}, "reference-count": 0, "publisher": "Wiley", "issue": "6Part13", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1", "start": {"date-parts": [[2014, 5, 29]], "date-time": "2014-05-29T00:00:00Z", "timestamp": 1401321600000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions", "start": {"date-parts": [[2014, 5, 29]], "date-time": "2014-05-29T00:00:00Z", "timestamp": 1401321600000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": ["aip.org"], "crossmark-restriction": true}, "short-container-title": ["Med. Phys."], "published-print": {"date-parts": [[2014, 6]]}, "DOI": "10.1118/1.4888483", "type": "journal-article", "created": {"date-parts": [[2014, 7, 11]], "date-time": "2014-07-11T12:04:40Z", "timestamp": 1405080280000}, "page": "258-258", "update-policy": "http://dx.doi.org/10.1063/aip-crossmark-policy-page", "source": "Crossref", "is-referenced-by-count": 0, "title": ["SU-E-T-153: Establish a Comprehensive Patient-Specific Plan QA Database for Instituitional Quality Control Program"], "prefix": "10.1002", "volume": "41", "author": [{"given": "X", "family": "Ding", "sequence": "first", "affiliation": []}, {"given": "A", "family": "Olszanski", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Scheuermann", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Bellerive", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Solberg", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2014, 5, 29]]}, "container-title": ["Medical Physics"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1118%2F1.4888483", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1118/1.4888483/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 5, 18]], "date-time": "2017-05-18T18:11:50Z", "timestamp": 1495131110000}, "score": 12.005574, "issued": {"date-parts": [[2014, 5, 29]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 6]]}, "issue": "6Part13"}, "URL": "http://dx.doi.org/10.1118/1.4888483", "archive": ["Portico"], "ISSN": ["0094-2405"], "issn-type": [{"value": "0094-2405", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T06:43:06Z", "timestamp": 1525761786054}, "reference-count": 1, "publisher": "Wiley", "issue": "35", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 14973, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Chemischer Informationsdienst"], "published-print": {"date-parts": [[1974, 9, 3]]}, "DOI": "10.1002/chin.197435012", "type": "journal-article", "created": {"date-parts": [[2016, 3, 19]], "date-time": "2016-03-19T17:22:21Z", "timestamp": 1458408141000}, "page": "no-no", "source": "Crossref", "is-referenced-by-count": 0, "title": ["ChemInform Abstract: THE INFLUENCE OF DIFFERENT FACTORS ON THE KINETICS OF POTENTIOSTATIC FORMING OF PASTED POSITIVE LEAD ELECTRODES"], "prefix": "10.1002", "volume": "5", "author": [{"given": "E.", "family": "SKOLUDA", "sequence": "first", "affiliation": []}, {"given": "ST.", "family": "OLSZANSKI", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "SZCZESNIAK", "sequence": "additional", "affiliation": []}, {"given": "ST.", "family": "TABAT", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2016, 3, 14]]}, "reference": [{"key": "10.1002/chin.197435012-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1016/0013-4686(74)85072-3", "article-title": "THE INFLUENCE OF DIFFERENT FACTORS ON THE KINETICS OF POTENTIOSTATIC FORMING OF PASTED POSITIVE LEAD ELECTRODES", "volume": "19", "author": "SKOLUDA", "year": "1974", "journal-title": "Electrochim. Acta"}], "container-title": ["Chemischer Informationsdienst"], "language": "de", "link": [{"URL": "http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.197435012", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.197435012", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T08:47:31Z", "timestamp": 1498294051000}, "score": 12.005574, "issued": {"date-parts": [[1974, 9, 3]]}, "references-count": 1, "journal-issue": {"published-print": {"date-parts": [[1974, 9, 3]]}, "issue": "35"}, "URL": "http://dx.doi.org/10.1002/chin.197435012", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0009-2975"], "issn-type": [{"value": "0009-2975", "type": "print"}]}], "items-per-page": 25, "query": {"start-index": 0, "search-terms": null}}, "custom_name_alias": "OLSZANSKI MAREK"}